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"I do not think we can rely on extrapolations of 
data on chemical carcinogenesis from experimental 
animals to humans, no matter how sophisticated 
or plausible these extrapolations may seem, 
until we know more about chemical carcinogenesis 
in humans" 
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Biological effects of genotoxic chemicals 
Body-foreign chemicals can possess intrinsic electrophilic 
properties or they can be activated into compounds with 
electrophilic properties. This process of activation either 
proceeds spontaneously, i.e. via a chemical reaction, or by 
means of enzymes. 
Electrophiles are capable to attack selectively nucleophilic 
sites of cellular constituents with vital importance, like 
lipids, proteins and nucleic acids. These interactions produce 
so-called "chemical-lesions", that can result in several 
disfunctions leading for instance to decreased cell-viability or 
even to necrosis and tissue degeneration (Mitchell, 1973; 
Lenders, 1983). When such electrophilic agents react with 
selective nucleophilic sites in DNA, e.g. at the N-7, C-8 and 
0-6 of guanidine, the induced lesions in the DNA may result in 
cytotoxic, mutagenic, carcinogenic or possibly teratogenic 
effects (Bora, 1982; Ehling, 1983; Schreiner, 1983; Sobéis, 1973; 
Zeller, 1975) In some cases, cytogenetic changes like chromosomal 
aberrations, are also attributed to prior DNA-damage by genotoxic 
chemicals (Bora, 1982; Ehling, 1983; Sobéis, 1973). Chemicals 
that do not possess electrophilic properties, but are capable of 
interacting with the DNA in other ways, e.g. acridine 
intercalation between adjacent nucleotide-bases, can also induce 
DNA lesions, thereby leading to genotoxic effects. 
Induced lesions in the DNA can be found in somatic as well as in 
germ cells. If the error occurs in a somatic cell, the result 
may be cell death or the formation of daughter cells with altered 
genes or in certain cases tumors. In case of a germ cell, 
transmission of the error to sequent generations may occur, 
leading to early spontanous abortions, inborn errors of 
metabolism, or other congenital defects which might be 
inheritable if fertility is not affected (Hook, 1982). 
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Well-known inherited diseases like hemophilia and various types 
of anaemia are generally connected with the existence of 
naturally occurring gene mutations (Carter, 1982). It is likely 
to assume that exposure to genotoxic agents will increase these 
natural hazards and may even induce new diseases. 
Indeed, interactions between electrophiles and DNA may initiate a 
broad spectrum of diseases. In most studies of the present 
thesis however, main attention has been paid to their mutagenic 
properties. 
Chemical mutagenesis and carcinogenesis 
The mechanisms involved in normal cells becoming malignant are 
still uncertain. However, the so called somatic mutation 
hypothesis, which is based on changes in genetic structure, has 
been accepted by many investigators to explain the primary events 
in chemical carcinogenesis. This theory, that mutation in 
somatic cells may lead to cancerous changes, was first suggested 
by Bauer (1928). 
Evidence in support of this hypothesis has been provided by, 
among others, the classical work on the heritable disease 
xeroderma pigmentosum (Cleaver, 1969; Röhrborn, 1976). When skin 
cells of people suffering from this disease are irradiated with 
UV-light, defective DNA-repair (resulting in a high mutation 
rate) and a high frequency of malignant transformations are 
observed in these cells. It has been suggested that a defect in 
the code for an endonuclease (involved in DNA-repair) is 
responsible for this failure to repair the UV-damaged DNA. The 
theory of Bauer to explain neoplasia had a serious limitation. 
It did not fit in with the observation that the state of 
established neoplasia is often remote from the initiating 
mutational event by a substantial time interval, which in some 
cases can span almost half the life-time of the host. 
It is now generally accepted that the process of carcinogenesis 
is a multi-step process, which may be divided into two main 
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Steps, namely initation and promotion (Scribner, 1978; Slaga, 
1980). Initiation is thought to be the primary event, which 
triggers the onset of the process of neoplasia. This may be the 
interaction of a DNA-damaging chemical with critical sites in the 
DNA. It is thought that the succeeding chain of events leading 
to the establishment of various malignant diseases, needs a 
second trigger, referred to as the promotion step. Many 
mutagenic agents have been shown to possess initiating 
properties. Several major studies have shown that there is a 
connection between mutagenic activities and carcinogenic 
activities of chemicals, with correlations ranging from about 67% 
to about 90% (Kawachi, 1980; McCann, 1975; Rinkus, 1979). This 
relationship has inspired the use of short-term mutagenicity 
assays in the detection of the potentially carcinogenic 
properties of chemicals. 
Metabolic activation and inactivation 
The metabolic transformations of body-foreign chemicals are 
divided into two types of reactions, phase I and phase II 
reactions (Sundberg, 1980). Phase I reactions, mainly concern 
oxidative processes, e.g. hydroxylations, epoxidations, 
oxidative dealkylations and deaminations, and to a lesser extent 
reductive and hydrolytic processes. Phase II reactions are 
involved in conjugations, for instance resulting in the synthesis 
of glucuronides, sulfates, acetates, and glutathione conjugates. 
Mostly, conjugation reactions follow phase I reactions, however 
the reverse also occurs. 
Many genotoxic chemicals which are unreactive as such can be 
biotransformed, predominantly by phase I processes, into highly 
reactive products, capable of interacting with nucleophilic 
centers (Wright, 1980). Formerly, phase II reactions were 
thought to be mainly involved in detoxification processes. 
However, it becomes more and more evident that also conjugation 
reactions, e.g. sulfation and acetylation are involved in the 
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activation processes (Irving, 1979). Even conjugation with 
glutathione can lead to the formation of highly reactive 
products. For instance, glutathione can accelerate the 
alkylation of DNA by compounds such as 1-nitroso-1-methyl-
3-nitrosoguanidine and nitrosomethylurethane, by reacting with 
these compounds, causing their decomposition into highly 
alkylating intermediates (Wheeler, 1972). Another example is the 
increased electrophilicity of 1,2-dihalogen alkanes by 
gluthatione conjugation (van Bladeren, 1980). 
The ability of genotoxic chemicals to exert their genotoxic 
activity is strongly dependent on the relative rates of 
activation and deactivation reactions, which determine the 
steady-state levels of the ultimate genotoxic intermediates and 
consequently the degree at which chemical lesions are induced. 
Any interference in the various enzyme activities involved in the 
toxification and detoxification process, will result in a change 
in concentration of the ultimate genotoxic metabolites and may 
lead to an altered ultimate genotoxicity. 
Many studies have provided evidence for the existence of 
considerable species-, strain-, sex- and inter individual 
variations in the metabolism of body-foreign chemicals (Conney, 
1974; ECETOC, 1982; Nebert, 1983; Harris, 1984; Juchau, 1983; 
Kato, 1979). In recent years, using advanced techniques for the 
isolation and purification of isoenzymic forms of 
drug-metabolizing enzymes, and the observation of differential 
immunologic cross-reactivity, substrate specificity and amino 
acid sequences of these purified forms, insight in such 
variations in biotransformation is increasing (Guengerich, 1979; 
Lu, 1980; Boobis, 1984; Davies, 1984; Hines, 1984; Coon, 1984). 
Many environmental chemicals are known to be capable of induction 
or inhibition of the metabolism of xenobiotics, probably by 
changing qualitatively and/or quantitatively the isoenzyme 
composition of the enzymes involved. Some well known modifiers 
are: phénobarbital, DDT, 3-methylcholanthrene, certain 
polychlorinated biphenyls, certain steroids, cigarette-smoke 
condensate and alcohol. The influence of diets on the metabolism 
of foreign compounds may be examplified by the observation of 
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Hietanen and Vainio (1973), that by feeding rats with a guinea 
pig diet, rat small-intestine benzo(a)pyrene hydroxylase activity 
could be 10-fold enhanced, reaching the same level as was 
measured in the guinea pig. 
As we have genetically determined colour of hair and eyes, each 
individual has also a unique genetically determined pattern of 
enzyme activities concerned in the biotransformation of 
body-foreign chemicals. Because of this there are large genetic 
differences in the biotransformation of xenobiotic chemicals, 
that are supposed to result in important variations in risk 
towards drug-toxicity, mutation, certain types of cancer and 
birth defects (Omenn, 1984). In humans genetically controlled 
polymorphisms of N-acetylation of isoniazid and hydrolysis of 
succinylcholine have been known for many years. Polymorphisms of 
oxidative metabolism, involving cytochrome-P450 enzymes, however, 
have been recognized only recently among human populations 
(Omenn, 1984). Recently, particular attention has been paid to 
the genetic control of the inducibility of xenobiotic-
metabolizing enzymes in animals as well as in humans. A 
wellknown example, is the Ah-locus that regulates the 
responsiveness of cells to various inducers belonging to the 
polycyclic aromatic compounds, such as 3-methylcholanthrene 
(Nebert, 1983). Several studies have indicated that a cytosolic 
receptor, capable of binding with high specificity certain 
polycyclic aromatic compounds, is produced by these Ah-genes. It 
is suggested, that when a cell is exposed to such inducers, the 
inducer-receptor complex formed activates certain other genes in 
the nucleus that regulate the biosynthesis of certain 
xenobiotic-metabolizing enzymes, e.g. certain cytochrome-P450 
isoenzymes. Consequently, a change in the critical balance 
between toxification and detoxification will occur, which may 
result in crucial changes in the (geno)toxicity of certain 
xenobiotics. There is substantial evidence now that in many 
animal species as well as in humans, genetically determined 
differences in the concentration of this receptor exist, which 
lead to the differences in inducibility. It is most likely that 
these or such like genetic differences in inducibility play an 
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important role in the variations in susceptibility towards the 
potential (geno)toxic activity of certain body-foreign chemicals. 
In addition it should be realized that the interaction of 
ultimate reactive intermediates with critical targets not only 
depends on the steady-state concentration and chemico-physical 
properties of the reactive intermediates but also on the 
susceptibility of the targets. Possibly this susceptibility may 
also be subjected to species-, strain-, sex- and even 
inter individual differences. 
Isolated hepatocytes in in-vitro genotoxicity studies. 
The liver is the predominant organ involved in the metabolism of 
body-foreign chemicals. Within the liver the xenobiotic-
metabolizing enzymes are concentrated mainly in the parenchymal 
cells, i.e. the hepatocytes, that comprise about 90% of the 
total liver mass and about 70% of the total amount of liver cells 
(Groothuis, 1982) . 
Intact hepatocytes can be isolated from liver tissue most 
properly by a perfusion technique using enzymatic (collagenase) 
digestion. With small animals, like rodent species, the 
perfusion technique can be applied to the whole liver, however in 
larger animals and in man, it is more suitable to perfuse only 
pieces of the liver. 
The isolated hepatocytes can be used either immediately as 
suspension, in short-term experiments, or they can be used as 
primary cultures for rather long-term studies (several days or 
weeks). In the latter case the isolated hepatocytes have to be 
brought into a primary culture, under special conditions to 
enable the hepatocytes to survive this period in a 
non-proliferating state. Both systems have their advantages and 
shortcomings when used in in-vitro genotoxicity studies. 
Freshly isolated hepatocytes may have a "shock" status because 
they have to adapt to the suboptimal conditions of their new 
environment. This may be examplified by an increased excretion 
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of proteins by these cells compared to the in-vivo situation 
(Princen, 1984). It is stated that hepatocytes cultured for 
about 24 hours have adapted and do not suffer from this aspect. 
Hepatocytes maintained as primary cultures, however, show several 
morphologic changes and a rapid decline in their 
biotransformational capacities, e.g. cytochrome-P450 catalyzed 
activities. Certain cytochrome-P450 isoenzymes are known to 
disappear although the total level of cytochrome-P450 may appear 
to be normal. This may be due to enhanced synthesis of other 
isoenzymic forms of cytochrome-P450 during culture. Several 
attempts have been made to artificially overcome the loss of 
certain enzyme activities. For instance, in order to preserve 
the "phénobarbital type P450,, levels in culture, phénobarbital 
was incorporated in the culture medium as inducer (Blaauboer, 
1985). The results of such approaches (although promising) seem 
stil far from ideal, because phénobarbital can also induce other 
enzymes (changing the metabolic profile as observed in-vivo), and 
may cause many other modifications to the cell, such as 
endoplasmatic reticulum proliferation, increased nuclear ploidy 
etc (Bridges, 1980). The dissimilar distribution of 
drug-metabolizing enzymes among hepatocytes in the liver in-vivo, 
e.g. centrilobular hepatocytes compared with periportal 
hepatocytes, is also present in a suspension of freshly isolated 
hepatocytes (Groothuis, 1982; Jungermann, 1982; Sweeney, 1981). 
However, it appeared that hepatocytes in primary culture for a 
longer period of time lost this heterogeneity. 
The value of freshly isolated hepatocytes for the assessment of 
the metabolite profile of several body-foreign chemicals and the 
overall biotransformational rate has been demonstrated 
extensively during the last 15 years (McMahon, 1980; Brouns, 
1981; Bridges, 1980; Roberfroid, 1980; Gould, 1983). In 
addition, isolated hepatocytes showed to be appropriate in models 
for the study of inhibition and/or induction of enzyme activities 
because of the possibility to control precisely the time and 
degree of exposure to xenobiotic chemicals. 
Recently, studies with isolated hepatocytes were extended to more 
detailed investigations of the relationship between metabolic 
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aspects and primary effects of genotoxic compounds (Brouns, 1981; 
present thesis). In this respect the use of intact hepatocytes 
instead of the commonly used subcellular liver preparations, e.g. 
the S9 (9000 xg supernatant fraction), offers the opportunity of 
having the xenobiotic-metabolizing enzymes in relative 
proportions and spatial relationships resembling the in-vivo 
situation. Especially the natural balance between activating and 
detoxificating reactions, which determines the concentrations of 
the reactive intermediates, may be properly preserved. Moreover, 
freshly isolated hepatocytes are capable to synthesize and 
recycle most of the cofactors needed for the optimal function of 
the activating and deactivating enzymes, whereas S9 fractions can 
only be enriched artificially with cofactors. 
As far as the endpoint of genotoxicity is concerned, various 
possibilities can be examined. Freshly isolated hepatocytes may 
be used in combination with a extra cellular response system, 
e.g. several genetically defined strains of Salmonella 
typhimurium, or on the other hand, the response system may be 
embodied within the hepatocyte, e.g. DNA-excision repair. The 







(DNA of Salmonella typh ) 
(a) (b) 




incubation,37 t . I h 
I - -Thymidine 
incubation, 37 " c , 2 h 
I 
extract ion of DNA 
I 







sample is mixed w i t h 
topagar and poured onto 
min imal agar plates 
37 ' с , 48 h 
counting of revertant colonies 
Fig. 1. A schematic representation of the hepatocyte/DNA-repair assay and the 
Salmonella/hepatocyte mutagenicity assay. In the Salmonella/hepatocyte assay, 
hepatocytes are used as metabolic system, and the reaction of reactive 
metabolites with the prokaryotic DNA of Salmonella typhimurium, mutating 
these histidine-auxotrophic bacteria back to histidine-autotrophy, is used 
as endpoint of genotoxicity. In the hepatocyte/DNA-repair assay, hepatocytes 
are used on one hand as the metabolizing system and on the other hand 
hepatocellular DNA-excision repair, evoked by adduct formation of reactive 
metabolites with the hepatocellular DNA, is used as endpoint of genotoxicity. 
DNA-excision repair is assayed via the measurement of SH-TdR-incorporation 
into the hepatocellular DNA. 
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OBJECTIVES OF THE INVESTIGATION 
The inter- and intraspecies variations in metabolic activation 
described in the previous chapter can be considered as important 
factors leading to differences in susceptibility to genotoxic 
chemicals. These differences make it vety difficult to 
extrapolate genotoxicity data obtained with animal based studies 
to the human being. 
In addition, thete is concetn about the limited ptedictive value 
of tesults of in-vitto studies on metabolic activation and 
genotoxicity. In this respect, for instance, there is doubt 
about the value of short-term in-vitro assays to identify 
potential carcinogens, in most of which subcellular liver 
fractions (S9) are used as metabolic system. 
The investigations of the present thesis primarily have the 
objective to gain more insight in the mechanisms underlying the 
differences mentioned above. A better understanding of this 
matter would help us in future to develop more reliable methods 
for the indentification of genotoxic chemicals and to make mote 
justified estimations of tisks to humans. 
The experimental approach of the present thesis mainly 
concentrates on: 
- in-vitro/in-vivo differences. 
- interspecies differences, in particular between laboratory 
animals and man. 
- inter individual differences. 
These problems were encountered by means of model studies with 
suspensions of freshly isolated hepatocytes derived from 
different species. 
The most relevant points that were studied ate these: 
- diffetences in metabolic activation between the 9000 xg livet 
supernatant ftaction (S9) and isolated intact hepatocytes 
(chapter III, IV, VII, IX). 
- the influence of modifiers of metabolism (i.e. ethanol, 
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paraoxon, and the cofactor acetyl-CoA) on the genotoxicity 
certain chemicals (chapter III, IV, VI, X). 
- differences in metabolic activation between isolât 
hepatocytes of different species including man (the species 
main interest) (chapter lli-ix.) 
- inter individual differences between human subjects studied wi 
isolated hepatocytes (chapter VII, VIII, IX). 
It has to be realized that not only DNA can serve as a taro 
molecule for electrophiles. Many other nucleophilic sites can 
attacked. One particular example was studied in the prese 
investigation, namely the species-dependent difference 
susceptiblity towards electrophilic agents of SH-groups 
hemoglobin (chapter XI). 
The results of these investigations are described in detail 
the chapters III-XI (consisting of prepublished or submitt 
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SUMMARY 
The mutagenicity of benzidine and 4-aminobiphenyl towards 
Salmonella typhimurium strain TA1538 was measured in the presence 
of isolated hepatocytes from rat, hamster and guinea pig. The 
mutagenic potency of these compounds was also assayed with S9 
(9000 xg supernatant) prepared from disrupted hepatocytes. The 
influence of acetyl-CoA, the cofactor for the acetylation 
reaction, on the mutagenicity of these arylamines was 
investigated. 
For all three animal species it was found that the mutagenicity 
of benzidine is higher with intact hepatocytes than with S9 
prepared from disrupted hepatocytes. Addition of acetyl-CoA to 
the S9 fraction increased the mutagenicity of benzidine. In 
contrast to benzidine , the mutagenicity of 4-aminobiphenyl 
appeared to be lower with hepatocytes than with S9. Addition of 
acetyl-CoA to the S9 fraction decreased the mutagenicity of 
4-aminobiphenyl. 
The mutagenic potency of 4-aminobiphenyl was almost equal in the 
presence of the liver preparations from the three different 
species, whereas obvious species differences were seen with 
benzidine. 
INTRODUCTION 
Responses to toxic substances are markedly influenced by 
interspecies differences. The basis for these variations is 
thought to be primarily the difference in the nature and extent 
of the biotransformation. This appears to be the case 
particularly when the metabolic pathways are very complex. 
Many chemical carcinogens, including certain arylamines, require 
metabolic activation to form reactive metabolites. Differences 
in activities of the enzymes necessary for the biotransformation 
can partly account for tissue and species differences in 
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genotoxicity of chemical compounds. For example the dog, lacking 
the N-acyltransferase activity involved in the metabolism of 
arylamines, develops only bladder tumors after receiving an 
unacetylated arylamine. Administration of the acetylated 
derivative results in liver and bladder tumors (Irving, 1979). 
It thus seems that acetylation is important for the formation of 
liver tumors by arylamines. 
Previous investigations have shown that isolated hepatocytes can 
be considered as a valuable tool for the study of the 
biotransformation of genotoxic agents, particularly those 
compounds that undergo complex reaction sequences (Billings, 
1977; Bock, 1976; Bos, 1982 and 1983; Glatt, 1981; Green, 1977). 
In the present study we compared the mutagenicity of two 
structurally related carcinogenic arylamines, benzidine and 
4-aminobiphenyl, in the Salmonella/hepatocyte assay using 
isolated hepatocytes of rat, hamster and guinea pig, paying 
particular attention to the role of acetylation in the 
biotransformation of these compounds. 
MATERIALS AND METHODS 
Chemicals 
Benzidine was purchased from Merck (Darmstadt, FRG). 
4-Aminobiphenyl was from Aldrich Europe (Beerse, Belgium). 
D-Biotin, L-histidine-HCl, collagenase type 1, nicotinamide 
adenine dinucleotide phosphate disodium salt (NADP) and 
glucose-6-phosphate (G-б-Р) dipotassium salt were obtained from 
Sigma (St. Louis, Missouri, USA). Acetyl-CoA was obtained from 
Boehringer (Mannheim, FRG). Purified agar was from Difco 
Laboratories, nutrient broth No. 2 from Oxoid Ltd. (Basingstoke, 
Great Britain). All other chemicals used were of high purity. 
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Animals 
The species of animals used in this study were as follows: male 
Wistar rats (app. 200 g), male albino guinea pigs (app. 400 g) 
and male golden Syrian hamsters (app. 90 g). 
Preparation of isolated hepatocytes 
The procedure was based on the methods described by Berry and 
Friend (1969) and by Seglen (1973) , with some modifications. All 
manipulations were performed under sterile conditions. Before 
the procedure, the animals were anesthetized by an i.p. 
injection of sodium pentobarbital (60 mg/ml distilled water); 
0.2 ml for rats, 0.7 ml for guinea pigs and 0.1 ml for hamsters. 
After pre-perfusion (15 min for rat and guinea pig, and 20 min 
for hamster) of the liver with a Ca2+-free HEPES buffer (pH 7.4), 
this buffer was replaced by a collagenase-containing HEPES buffer 
(for rat and guinea pig 0.05%, for hamster 0.04% w/v collagenase; 
pH 7.6) and pre-perfusion was continued for another 10 min. For 
rats and guinea pigs the perfusion rate was 40 ml/min, for 
hamsters it was 30 ml/min. The crude cell suspension was treated 
according to the method of Seglen (1973) , and the final pellet 
was resuspended in a Ca2+-containing HEPES-TES buffer solution 
6 (pH 7.6) and diluted to a density of 10 χ 10 cells/ml. 
Trypan-blue exclusion showed the presence of about 95% viable 
cells. 
Preparation of S9 mix from isolated hepatocytes 
10 ml of a suspension of 10 χ 10 liver cells/ml were centrifugea 
at 1600 xg for 2 min. The pellet was suspended in 5 ml of 
HEPES-TES buffer containing 2% albumin, glucose-6-phosphate 
(15 umoles/ml) and NADP (12 umoles/ml). This suspension was 
sonicated twice for 30 sec, with an interval of 25 sec in an MSE 
Ultrasonic Disintegrator (100 W) at maximal energy. During this 
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step the suspension was cooled on ice. Next, the sonicated 
suspension was centrifuged at 9000 xg for 20 min. To the 
supernatant, 5 ml of the HEPES-TES buffer containing albumin, 
glucose-6-phosphate, NADP, and as indicated in the Results 
section, 0.2 or 2 mM acetyl-CoA were added. All manipulations 
were performed at 4 oC and under sterile conditions. 
Salmonella/hepatocyte suspension assay 
The Salmonella/hepatocyte suspension assay was carried out as 
follows. In a shaking waterbath (210 rpm), closed sterile vials 
(inner diameter 24 mm, height 55 mm), each containing 387.5 ul of 
hepatocyte suspension (10 χ 10 viable cells/ml), 0.1 ml of an 
overnight-grown suspension of Salmonella typhimurium (about 1.5 χ 
g 
10 bacteria/ml) and 12.5 ul of a solution (in DMSO) of the 
compound under test, were incubated at 37 oC for 2 h. Next, each 
mixture was plated with a molten topagar containing only biotin 
(no histidine). 
The number of revertant colonies was counted after incubation at 
37 oC for 48 h. 
Salmonella/disrupted hepatocyte suspension assay 
In this assay, Salmonella typhimurium and the compound under test 
were incubated as described for the Salmonella/hepatocyte assay. 
However, instead of a suspension of hepatocytes, we added 
387.5 ul of S9 prepared from an equal amount of the same isolated 
hepatocytes as used in the parallel Salmonella/hepatocyte assay. 
Molten topagars contained only biotin (no histidine). 
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RESULTS 
Mutagenicity of benzidine and 4-aminobiphenyl 
In Figure 1A the mutagenicity of benzidine is shown towards 
Salmonella typhimurium TA1538 using liver preparations of rat, 
hamster or guinea pig as the metabolic factor. The results show 
that in the rat and hamster the mutagenicity of benzidine was 
much higher with intact hepatocytes than with S9 prepared from 
disrupted hepatocytes. In the guinea pig liver preparations this 
difference was less evident. The mutagenic potency of benzidine 
with the rat and hamster liver preparations was relatively high. 
In contrast, with the guinea pig liver preparations the mutagenic 
potency of benzidine was almost negligible. 
Figure IB shows the mutagenicity of 4-aminobiphenyl towards 
Salmonella typhimurium TA1538 using intact hepatocytes and S9 
prepared from disrupted hepatocytes as the metabolic factor. In 
contrast to benzidine, for all three species, the mutagenicity of 
4-aminobiphenyl was higher when S9 was used instead of intact 
hepatocytes. No obvious interspecies differences in mutagenic 
potency of 4-aminobiphenyl were observed when liver preparations 
of rat, hamster and guinea pig were applied as the metabolic 
factor. 
In the presence of rat and hamster hepatocytes or S9, 
4-aminobiphenyl showed a much lower mutagenic potency than 
benzidine. When guinea pig S9 was used, 4-aminobiphenyl was 
slightly more mutagenic than benzidine. 
Influence of acetyl-CoA 
The effects of acetyl-CoA, the cofactor for the acetylation 
reaction, on the mutagenicity of benzidine and 4-aminobiphenyl 
are presented in Figures 1 and 2, respectively. For each of the 
three species, it was observed that the mutagenicity of benzidine 
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Fig. 1. Mutagenicity of benzidine (A) and 4-aminobiphenyl (B) towards 
Salmonella typhimurium TAI 538 after metabolic activation with intact 
hepatocytes (·), 9000 xg supernatant prepared from disrupted hepatocytes (0), 
9000 xg supernatant prepared from disrupted hepatocytes supplemented with 
acetyl-CoA, 0.1 mM (Л) or 1 mM (D), from rat, hamster and guinea pig. Values 
are the means of triplicate determinations. 
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acetyl-CoA. This increase in mutagenicity was dependent on the 
concentration of acetyl-CoA. On the contrary, the mutagenicity 
of 4-aminobiphenyl decreased when acetyl-CoA was added to the S9. 
For each of the three species the mutagenicity values at 1 mM 
acetyl-CoA were lower than those at 0.1 mM. The decrease was 
most pronounced after incubation with the guinea pig S9 fraction, 
when the mutagenicity of 4-aminobiphenyl completely disappeared 
in the presence of 1 mM acetyl-CoA. 
DISCUSSION 
In many animal species, N-acetylation is a major pathway in the 
metabolism of arylamines (Irving, 1979). N-Acetylation can be 
followed by reactions such as N-hydroxylation and subsequent 
ester ification, resulting in the generation of electrophilic 
metabolites that can react with DNA. For carcinogenic amines and 
their N-acetyl-derivatives, N-hydroxylation is an essential step 
in the metabolic activation and an absolute requirement for their 
carcinogenic action (Irving, 1979). 
The present results demonstrate the great importance of the 
acetylation reaction in the biotransformation of benzidine and 
4-aminobiphenyl into mutagenic products. It is interesting that 
for the bifunctional arylamine, benzidine, the acetylation 
reaction appears to increase the mutagenicity (Figure 1A) whereas 
for the monofunctional arylamine, 4-aminobiphenyl, the 
acetylation results in a reduction of mutagenic potency 
(Figure IB). 
The fact that acetylation is a major metabolic pathway for 
arylamines has led to the proposal of Morton et al. (1979) that 
it may precede N-hydroxylation, thus leading, in the case of 
benzidine, to the production of N-hydroxy-NfN'-diacetylbenzidine. 
These authors also showed that this intermediate can act as a 
good substrate for an acyltransferase enzyme, generating products 
highly mutagenic towards Salmonella typhimurium. Lazear et al. 
(1979) and Tanaka et al. (1981) showed that N-acetylbenzidine 
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and NfN'-diacetylbenzidine are far more mutagenic in the Ames 
assay than the parent compound, benzidine. Bos et al. (1984) 
recently showed that intact rat hepatocytes were able to convert 
benzidine to a great extent into its acetylated derivatives. In 
contrast, the S9 liver fraction could only acetylate benzidine 
when the cofactor for the acetylation, acetyl-CoA, was added to 
the incubation medium. Our observation that benzidine is more 
mutagenic when intact hepatocytes instead of S9 are used as 
metabolic factor, are in agreement with the previous findings. 
When guinea pig liver preparations were used as the metabolic 
factor, benzidine appeared to be almost non-mutagenic 
(Figure 1A). This is in accordance with the finding of Morton et 
al. (1979), who showed that liver microsomes of rat and hamster, 
unlike those of guinea pig, were able to convert 
Ν,Ν'-diacetylbenzidine into N-hydroxy-NjN'-diacetylbenzidine. 
The non-mutagenicity of benzidine in the presence of guinea pig 
liver preparations might be due to a lack of N-hydroxylation. 
McMahon et al. (1980) showed that N-hydroxy-4-aminobiphenyl is a 
major metabolite of 4-aminobiphenyl after incubation with 9000 xg 
liver supernatant of rat, hamster and guinea pig. Miller et al. 
(1961) reported that in rat in vivo 4-aminobiphenyl was 
metabolized by successive N-acetylation and N-hydroxylation to 
N-hydroxy-4-acetamidobiphenyl. Connor et al. (1983) recently 
showed that in the Ames-assay 4-aminobiphenyl was significantly 
more mutagenic than the acetylated derivative, 
4-acetamidobiphenyl. These authors suggested that the lower 
mutagenicity of 4-acetamidobiphenyl, was probably due to a lower 
N-hydroxylation of this compound. These findings and our 
mutagenicity data of 4-aminobiphenyl lead to the assumption that 
for all three animal species in intact hepatocytes and in S9 
supplemented with acetyl-CoA, 4-aminobiphenyl is converted into 
the less mutagenic 4-acetamidobiphenyl. 
The data of Figures 1 and 2 show that especially with intact 
hepatocytes of rat and hamster as the metabolic factor, benzidine 
is much more mutagenic than 4-aminobiphenyl. This is in 
agreement with the findings of Bos et al. (1980) who found that 
the mutagenic activity in urine of rats was much higher after 
35 
treatment of these animals with benzidine than after an equal 
dose of 4-aminobiphenyl. These authors also showed that in an 
intrasanguineous host-mediated assay with rats, benzidine was 
more mutagenic than 4-aminobiphenyl (Bos, 1982). 
Many interspecies differences in the toxic effects of arylamines 
are reported. The present results emphasize that isolated 
hepatocytes may be very helpful in the study of parameters 
determining such variations. This holds particularly for studies 
of interspecies differences in the multi-step activation of 
premutagens, such as certain arylamines. 
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SUMMARY 
The metabolic activation of N-acetylbenzidine (MABZ) and 
Ν,Ν'-diacetylbenzidine (DABZ), forming products mutagenic towards 
Salmonella typhimurium TA1538, was studied with isolated 
hepatocytes from rat, hamster and guinea pig and the S9 fraction 
(9000 xg supernatant) prepared from these hepatocytes. Special 
attention was given to the influence of acetyl-CoA, the cofactor 
for N-acetylation, on the mutagenicity of these arylamides. 
The rat and guinea pig S9 preparation activated MABZ as well as 
DABZ to a much higher degree than the intact hepatocytes of these 
animal species. Addition of acetyl-CoA to the S9 preparation 
decreased the mutagenicity of MABZ and DABZ. 
On the contrary, for the hamster the mutagenicity of MABZ and 
DABZ appeared to be lower with the S9 preparation than with 
intact hepatocytes. Addition of acetyl-CoA to the S9, here 
increased the mutagenic activity of these arylamides. 
In the presence of intact hepatocytes obvious interspecies 
differences were observed in the activation of MABZ and DABZ. 
DABZ was far more effectively activated by hamster hepatocytes 
than by rat hepatocytes. This was not found with MABZ. Both 
substrates were poorly activated by guinea pig hepatocytes. 
INTRODUCTION 
The arylamine benzidine (BZ) was epidemologically shown to be a 
human carcinogen, producing tumors of the urinary bladder (Zavon, 
1973). Tumors of the bladder have also been observed in dogs 
following a long period of feeding with BZ (Spitz, 1950). In 
experimental animals like mice, rats and hamsters tumors of the 
liver have been observed. 
In the last few years BZ has received an increasing amount of 
attention. Interest in this arylamine was partly stimulated by 
the observation that BZ-based azo dyes can be reduced to free BZ 
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by azoreductase of the intestinal flora and the liver. Azo dyes 
derived from BZ and its congeners are commonly used in dyeing 
textiles, in plastic, paper, leather and wood stains. 
Recent investigations demonstrated that following the 
administration of BZ-based dyes to people and animals, BZ, MABZ 
and DABZ could be detected (Bos, 1984; Lowry, 1980; Lynn, 1980; 
Tanaka, 1981). 
One of the major routes for the metabolism of carcinogenic 
arylamines in a variety of species, including man, involves 
N-acetylation (Bos, 1984; Haley, 1982; Lower, 1973; Morton, 1979; 
Troll, 1963). The enzyme responsible for this metabolic step is 
a acetyl-CoA-dependent N-acetyltranferase present in mammalian 
liver. The N-acetylated products are subject to further 
biotransformation like N-hydroxylation, and ester ification of the 
N-hydroxy-moiety catalyzed by sulfotransferase (Morton, 1980) or 
(N,0)-acyltransferase (Morton, 1979) to produce genotoxic 
products. In a previous study we found that N-acetylation in 
rat, hamster and guinea pig hepatocytes is an important step in 
the metabolic activation of BZ into mutagenic products. 
In the present investigation we compared the mutagenicity of MABZ 
and DABZ - the acetylated derivatives of BZ - in the 
Salmonella/hepatocyte assay using isolated hepatocytes of rat, 
hamster and guinea pig. Experiments with intact hepatocytes and 
the postmitochondrial fraction (S9) from these cells were 
designed to evaluate the significance of the N-acetylation 
reaction in the mutagenic activation of MABZ and DABZ. 
MATERIALS AND METHODS 
Chemicals 
MABZ and DABZ were obtained from ICN Pharmaceuticals, Inc. 
(Plainview, NY, USA). and were purified by recrystallization 
(purity>97%, checked with HPLC). D-Biotin, L-histidine-HCL, 
collagenase type 1, nicotinamide adenine dinucleotide phosphate 
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(NADP) disodium salt and glucose-6-phosphate (G-6-P) dipotassium 
salt were obtained from Sigma (St. Louis, Missouri, USA). 
Acetyl-CoA was obtained from Boehringer (Mannheim, FRG). 
Purified agar was from Difco Laboratories, nutrient broth No. 2 
from Oxoid Ltd. (Basingstoke, Great Britain). All other 
chemicals used were of high purity. 
Animals 
The species of animals used in this study were male Wistar rats 
(app. 200 g), male albino guinea pigs (app. 400 g) and male 
golden Syrian hamsters (app. 90 g). 
Preparation of isolated hepatocytes 
The procedure was based on the methods described by Berry and 
Friend (1969) and by Seglen (1973), with some modifications. All 
manipulations were performed under sterile conditions. Before 
the procedure, the animals were anesthetized by i.p. injection 
of sodium pentobarbital (60 mg/ml distilled water); 0.2 ml for 
rats, 0.7 ml for guinea pigs and 0.1 ml for hamsters. After 
pre-perfusion (15 min for rat and guinea pig, and 20 min for 
hamster) of the liver with a Ca2+-free HEPES buffer (pH 7.4), 
this buffer was replaced by a collagenase-containing HEPES buffer 
(for rat and guinea pig 0.05%, for hamster 0.04% (w/v) 
collagenase; pH 7.6) and perfusion was continued for a further 10 
min. For rats and guinea pigs the perfusion rate was 40 ml/min, 
for hamsters it was 30 ml/min. After incubation of the crude 
cell suspension in a shaking waterbath (120 rpm) at 37 oC for 30 
min, filtration, gentle centrifugation and cellwashing, the final 
pellet was resuspended in a HEPES-TES buffer solution (pH 7.6) 
containing 2% albumin. This suspension was then diluted to a 
density of 10 χ 10 viable cells/ml. Trypan-blue exclusion 
indicated the viability to be about 95%. 
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Preparation of S9 mix from isolated hepatocytes 
10 ml of a suspension of 10 χ 10 liver cells/ml were centrifuged 
at 1600 xg for 2 min. The pellet was suspended in 5 ml of 
HEPES-TES buffer containing 2% albumin, glucose-6-phosphate (15 
umoles/ml) and NADP (12 umoles/ml). This suspension was 
sonicated twice for 25 sec, with an interval of 30 sec in an MSE 
Ultrasonic Disintegrator (100 W) at maximal energy. During this 
step the suspension was cooled on ice. Next, the sonicated 
suspension was centrifuged at 9000 xg for 20 min. To the 
supernatant, 5 ml of the HEPES-TES buffer containing albumin, 
glucose-6-phosphate, NADP, and as indicated in the Results 
section, 0.2 or 2 mM acetyl-CoA were added. All manipulations 
were performed at 4 oC and under sterile conditions. 
Saltnonella/hepatocyte suspension assay 
The Salmonella/hepatocyte suspension assay was carried out as 
follows. In a shaking waterbath (210 rpm), closed sterile 
scintillation vials (20 ml) each containing 387.5 ul of 
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hepatocyte suspension (10 χ 10 viable cells/ml), 0.1 ml of an 
overnight-grown suspension of Salmonella typhimurium, strain 
g 
TA1538 (about 1.5 χ 10 bact./ml) and 12.5 ul of a solution (in 
DMSO) of the compound under test, were incubated at 37 oC for 2 
h. Next, each mixture was plated with a molten top agar 
containing only biotin (no histidine). The number of revertant 
colonies was counted after incubation at 37 oC for 48 h. 
Salmonella/disrupted hepatocyte suspension assay 
In this assay. Salmonella typhimurium, TA1538, and the compound 
under test were incubated as described for the 
Salmonella/hepatocyte assay. However, instead of a suspension of 
hepatocytes, we added 387.5 ul of S9 mix prepared from an equal 




Mutagenicity of MABZ and DABZ 
Figure 1A shows the mutagenicity of MABZ towards Salmonella 
typhimurium TA1538 after metabolic activation with intact 
hepatocytes and S9 mix prepared from disrupted hepatocytes of 
rat, hamster and guinea pig. Highest values were obtained with 
the liver preparations of rat and hamster. These results further 
demonstrate that with the S9 mix of rat and guinea pig the 
mutagenic activation of MABZ is much higher than with intact 
hepatocytes of these species. In contrast, intact hamster 
hepatocytes seem to activate MABZ better than the S9 mix, at 
concentrations of MABZ exceeding 25 uM. 
Figure IB represents the mutagenicity of DABZ towards Salmonella 
typhimurium TA1538 after metabolic activation by the various 
liver preparations. As was observed for MABZ (Figure ΙΑ), the 
mutagenicity of DABZ was also significantly higher with S9 mix 
than with intact hepatocytes of rat and guinea pig. However, 
with hamster hepatocytes the mutagenic activity of DABZ at high 
concentration appeared to be higher than with the S9 mix, whereas 
at low concentrations of DABZ the S9 mix was more active. Again 
the guinea pig liver preparations were found to be poor 
activators, whereas with the rat and hamster liver preparations a 
relatively high mutagenic activity of DABZ was obtained. 
However, hamster hepatocytes appeared far more effective in 
activating DABZ than rat hepatocytes. 
In the presence of the rat hepatocytes, the mutagenic potency of 
MABZ was much higher than that of DABZ. However, such an obvious 
difference was not observed with the hamster or guinea pig 
hepatocytes. 
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Fig. 1. Mutagenicity of MABZ (A) and DABZ (B) towards Salmonella typhimurium 
TA1538 after metabolic activation with intact hepatocytes (·), 9000 xg 
supernatant prepared from disrupted hepatocytes (Ο), 9000 xg supernatant 
prepared from disrupted hepatocytes supplemented with acetyl-CoA, 0.1 mM (A), 
or 1 mM (D), from rat, hamster and guinea pig. Values are the means of 
triplicate determinations. 
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Influence of acetyl-CoA 
Figures IA and IB also show the effects of the addition of 
acetyl-CoA to the S9 preparation on the mutagenicity of MABZ and 
DABZ. For the rat and guinea pig, supplementation of acetyl-CoA 
- the cofactor for N-acetylation - caused a decrease in 
mutagenicity of MABZ as well as of DABZ. On the contrary, when 
acetyl-CoA was added to the hamster S9 preparation the mutagenic 
activity of MABZ as well as DABZ increased. The influence on 
mutagenicity appeared to be concentration dependent, being 
greater at 1 mM than at 0.1 mM acetyl-CoA. 
DISCUSSION 
In a previous study we demonstrated that enrichment of the S9 mix 
of rat, hamster and guinea pig hepatocytes with acetyl-CoA, 
increased the capacity of mutagenic activation of benzidine 
(Neis, 19Θ4). The present results show that for the rat and 
guinea pig, addition of acetyl-CoA to the S9 mix decreased the 
mutagenicity of MABZ and DABZ. A reversed effect of acetyl-CoA 
was found with the hamster S9 mix (Figures 1A and IB). 
Apparently, for guinea pig liver preparations, the difference 
between the intact cells and the S9 mix in their capacity to 
activate these arylamides disappears on the addition of up to 
1 mM acetyl-CoA. For rat-liver preparations, this difference is 
reduced by the addition of acetyl-CoA (Figures 1A and IB). 
Recently, Bos et al. (1984) reported that intact rat hepatocytes 
were able to acetylate BZ to a great extent into MABZ and DABZ. 
The S9 mix could only acetylate BZ when acetyl-CoA was added to 
the incubation medium. We therefore suggest that in the S9 mix a 
low acetylating activity (due to a lack of acetyl-CoA) is 
overruled by a high activity of deacetylation. On the other 
hand, in the intact hepatocytes and in the S9 mix supplemented 
with acetyl-CoA, the equilibrium of the acetylation/deacetylation 
reaction favours acetylation. This means that after incubation 
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of the latter systems with MABZ or DABZ, mainly DABZ will be 
present. 
We observed a low mutagenic activation of DABZ compared with MABZ 
and BZ (Neis, 1984) using intact rat hepatocytes. This is in 
agreement with in vivo carcinogenicity and DNA-binding studies 
(Martin, 1982 and 1983; Morton, 1981). Morton et al. (1981) 
presented carcinogenicity data showing BZ to be more potent than 
DABZ in the rat. Martin et al. (1982 and 1983) recently 
reported that administration of BZ or MABZ to rat or mice 
produced a single hepatic DNA adduct, which was identified as 
N- (deoxyguanosin-8-yl)-N'-acetylbenzidine, showing 
N-OH-N'-acetylbenzidine as a proximate carcinogenic species. 
Administration of DABZ produced only barely detectable binding. 
These authors suggested that DABZ was a poor substrate for 
N-hydroxylation in rats in vivo or possibly that it was rapidly 
detoxified. 
Our observed high mutagenicity of MABZ and the even slightly 
higher activity of DABZ with hamster hepatocytes favours the idea 
that N-OH-N,Ν'-diacetylbenzidine rather than 
N-OH-N'-acetylbenzidine is the proximate genotoxic species in the 
hamster. This concept is in agreement with the finding of Morton 
et al. (1979) that hamster-liver preparations are far more 
active in N-hydroxylation of DABZ than rat or guinea pig liver 
preparations. These authors also showed that 
N-OH-N,N'-diacetylbenzidine was a good substrate for an 
(N,0)-acetyltransferase, generating products highly mutagenic to 
Salmonella typhimurium. 
We observed relatively low mutagenic activities of BZ (Neis, 
1984), MABZ and DABZ after metabolic activation with guinea pig 
hepatocytes and S9 mix. This may be due to a low N-hydroxylating 
capacity (Miller, 1964; Morton, 1979) or a high detoxification of 
formed N-hydroxy-metabolites (Razzouk, 1980) in the guinea pig. 
The present data, together with those obtained from studies 
mentioned above, can be summarized in a tentative scheme, as 
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Fig. 2. Tentative scheme for the metabolic activation of MABZ and DABZ in rat 
and hamster. 
Differences found between rat and hamster may contribute to 
differences in the substrate specificity of N-hydroxylating 
enzymes. The low capacity of mutagenic activation of the guinea 
pig is probably caused by poor N-hydroxylation of both MABZ and 
DABZ, or to an effective detoxification. 
Because of the importance of the N-acetylation in the metabolic 
activation of arylamines, we suggest that intact hepatocytes are 
probably a better tool in the screening of arylamine genotoxicity 
than subcellular liver fractions, like the commonly used S9 mix. 
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SUMMARY 
DNA-excision repair in isolated hepatocytes of rat, hamster and 
guinea pig, as a result of exposure to benzidine (BZ), 
N-acetylbenzidine (MABZ) and N ,N'-diacetylbenzidine (DABZ), was 
measured as 3H-Thymidine (3H-TdR) incorporation into the 
hepatocellular DNA. 
With the hepatocytes of all three animal species a dose-dependent 
DNA-repair was found after exposure of these cells to all three 
compounds. However, obvious interspecies differences were 
observed in the extent of the induced DNA-repair. BZ, MABZ and 
DABZ were more effective in inducing a repair-response in hamster 
hepatocytes than in rat hepatocytes. All three substrates 
induced only a slight increase in DNA-repair in the guinea pig 
hepatocytes. 
BZ, MABZ and DABZ appeared to be equal active in inducing 
DNA-repair in the guinea pig hepatocytes. However, in the rat 
and hamster hepatocytes MABZ and DABZ induced a far more 
effective DNA-repair than BZ. The results indicate, that the 
N-acetylation plays an important role in the metabolic activation 
of BZ to DNA-damaging products in the rat and hamster liver. 
INTRODUCTION 
The arylamine BZ has been epidemiologically shown to produce 
tumors of the urinary bladder in humans (Zavon, 1973). In dogs 
also tumors of the bladder have been observed after feeding of 
BZ. In rodent species like rat, hamster and mouse, tumors of the 
liver have been observed. 
The carcinogenic activity of many precarcinogens is believed to 
result mainly from the interaction of the ultimate carcinogenic 
metabolites with the DNA of the target cells. Therefore 
measurement of alterations in the DNA after exposure to these 
compounds may be a suitable tool for detecting their potential 
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genotoxicity. The measurement of DNA-excision repair in 
hepatocytes as unscheduled DNA-synthesis (UDS) following chemical 
induced DNA-damage has been shown to be a valuable tool in 
assessing carcinogenic properties of chemicals (Brouns, 1979; 
McQueen, 1981; Mitchell, 1983; Olson, 1983; Probst, 1981; 
Williams, 1982) . 
We recently showed that BZ, MABZ and DABZ are metabolized by 
isolated hepatocytes of rat, hamster and man to products highly 
mutagenic towards Salmonella typhimurium TA1538 (Neis, 1984, 
1985a and 1985b). However, all three compounds were poorly 
activated by guinea pig hepatocytes (Neis, 1984 and 1985b). In 
this Salmonella/hepatocyte assay, bacterial mutagenicity can be 
used as a parameter of extra-hepatocellular appearance of 
proximate or ultimate mutagenic metabolites. Whereas, 
hepatocellular DNA-excision repair can be used as endpoint for 
genotoxic effects within the hepatocytes. 
In the present study we have examined the capability of 
suspensions of freshly isolated hepatocytes of rat, hamster and 
guinea pig, to metabolize BZ, MABZ and DABZ to DNA-damaging 
products by measurement of DNA-excision repair, estimated via the 
incorporation of 3H-TdR into the hepatocellular DNA with 
liquid-scintillation counting. 
MATERIALS AND METHODS 
Chemicals 
Chemicals were obtained from the following companies: BZ was 
from Merck (Darmstadt, FRG); MABZ and DABZ were obtained from ICN 
Pharmaceutical Inc. (Plainview, NY, USA). MABZ was purified by 
recrystallization from ethanol. DABZ contained 18% MABZ and was 
purified as follows: the DABZ sample was dissolved in IN HCl and 
the DABZ was extracted with ethylacetate and evaporated to 
dryness. This preparation was further purified by 
recrystallization from ethanol. (Purity: MABZ>97%, DABZ>99%, 
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checked with HPLC). Collagenase (from Clostridium histolyticum) 
was obtained from Boehringer (Mannheim, FRG); Eagle's minimal 
essential medium including Hank's salts, and foetal calf serum 
were from biomed (Gibco); 3H-Thymidine (3H-TdR), spec. act. 26 
Ci/mmol was from the Radiochemical Centre (Amersham, UK). All 
other chemicals were of high purity. 
Preparation of isolated hepatocytes 
Male Wistar rats (app. 200 gr), male albino guinea pigs 
(app. 400 gr) and male golden Syrian hamsters (app. 100 gr) were 
used for the preparation of isolated hepatocytes. The 
hepatocytes were isolated by a collagenase perfusion technique as 
previously described (Neis, 1984 and 1985b). All manipulations 
were carried out under sterile conditions. 
DNA-repair assay 
Hepatocellular DNA-excision repair was measured as 3H-TdR 
incorporation into DNA by a rapid and simple technique via liquid 
scintillation counting as described by Brouns et al. (1979), with 
slight modifications. The isolated hepatocytes were resuspended 
in Eagle's minimal essential medium, supplemented with Hank's 
salts, 10% foetal calf serum, streptomycin 0.01% and penicillin-G 
100 U/ml. In a shaking waterbath (120 rpm), closed scintillation 
vials (20 ml) each containing 487.5 ul of hepatocyte suspension 
(1 χ 10 viable cells/ml) and 12.5 ul of a solution (in DMSO) of 
the compound under test, were incubated in triplicate at 37 oC 
for 1 h. To three vials, serving as control, 12.5 ul DMSO was 
added. After incubation, 3H-TdR was added to each vial to a 
final concentration of 1 uCi/ml, whereafter incubation was 
continued for 2 h. Next, 2 ml of saline was added to each vial. 
Each mixture was transferred to centrifuge tubes and centrifuged 
at 3000 xg for 10 min, and the supernatants were carefully 
decanted. To the cell pellets, 1 ml 6 M NaSCN solution was added 
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under vigorous shaking, and were left to stand overnight at room 
temperature to achieve complete lysis of the cells. 
Subsequently, after addition of 1 ml carrier DNA solution 
(0.1 mg DNA/ml), macromolecules were precipitated by addition of 
2 ml 20% ice-cold TCA solution under vigorous shaking. After 
standing at -20 oC for 30 min the tubes were centrifuged at 
3000 xg for 15 min. The pellet was washed once with 70% ethanol 
and once with cold 0.5N PCA, after which the precipitated DNA was 
selectively solubilized with 0.5 ml 0.5N PCA at 80 oC for 60 min. 
The tubes were then centrifuged at 3000 xg for 15 min, and the 
supernatant added to scintillation vials. After addition of 5 ml 
Aqua Luma to each vial, the 3H-radioactivity was measured by a 
Philips liquid-scintillation analyzer (efficiency 39-42%). 
RESULTS 
BZ, MABZ and DABZ evoked DNA-repair 
Benzidine and its acetylated derivatives evoked UDS in the 
isolated hepatocytes of rat, hamster and guinea pig. The 3H-Tdr 
incorporation was found to be concentration dependent (Figure 1). 
Almost in all cases, beyond a certain concentration of test 
compound an abrupt decline in incorporation of 3H-TdR was 
observed, possibly due to injurious or inhibitory effects on the 
processes involved in the DNA-repair, since the cellular 
viability (as judged by trypan-blue exclusion) was almost 
uneffected at the concentrations used. 
Rat 
From the concentration-effect curves it can be derived that in 
the hepatocytes of rat an obvious increase in DNA-repair 
synthesis occurred when exposed to BZ, MABZ and DABZ. The 
acetylated derivatives, e.g. MABZ and DABZ, appeared to induce a 
higher DNA-repair than the parent compound BZ. 
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Fig. 1. Incorporation of ЗН-TdR into the DNA of isolated hepatocytes of rat, 
haraster and guinea pig as result of exposure to different concentrations of 
BZ(·), MABZ(A) and DABZ(•) . Values are the means (SEM-values less than 10% 
of the mean) of three separate experiments with hepatocyte preparations of 
different animals, each assayed in triplicate. 
Hamster 
The levels of DNA-repair evoked in hamster hepatocytes were about 
the same as those in the rat hepatocytes, however for MABZ and 
DABZ the maximum increase in 3H-Tdr incorporation was reached at 
concentrations 10 times lower than with the rat hepatocytes. in 
the hamster hepatocytes, like in the rat hepatocytes, MABZ and 
DABZ appeared more effective than BZ. 
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Guinea pig 
All three compounds appeared to evoke only a slight increase in 
repair in the guinea pig hepatocytes. This low increase in 
DNA-repair is probably not attributed to a low activity of the 
DNA-repair system of these cells, because in reference 
experiments we found a relatively active DNA-repair, when exposed 
to 4-nitroquinoline-l-oxide, a well known DNA damaging agent. 
With the guinea pig hepatocytes, in contrast to the rat and 
hamster hepatocytes, almost similar concentration-effect curves 
were obtained with all three compounds. 
DISCUSSION 
Many investigations have shown that DNA-excision repair 
represents a reliable indicator of prior DNA-damage caused by 
chemical carcinogens. The present data show that in rat, hamster 
and guinea pig hepatocytes, repair synthesis is evoked in 
response to treatment with BZ, MABZ and DABZ, demonstrating the 
capability of these cells to metabolize these compounds to 
DNA-damaging products (Figure 1) . 
In a previous study (Neis, 1984) we found with rat, hamster and 
guinea pig hepatocytes, that the N-acetylation is an important 
step in the metabolic activation of BZ to products mutagenic to 
Salmonella typhimurium. The present results show that in rat and 
hamster hepatocytes, the acetylated BZ-derivatives MABZ and DABZ 
are more effective than BZ itself (Figure 1). This supports the 
concept that N-acetylation is a very important step in the 
metabolic activation of BZ to genotoxic products in rat and 
hamster liver. Martin et al. (1980) have also reported the 
importance of the N-acetylation reaction in BZ genotoxicity. 
These authors showed that in the liver of rats or mice exposed to 
BZ only one major DNA-adduct was obtained namely 
N-(deoxyguanosin-8-yl)-N'-acetylbenzidine. They suggested from 
these findings that the most likely proximate carcinogenic 
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metabolite of BZ is N-OH-N'-MABZ. 
A more effective DNA-repair, as response to exposure to BZ, MABZ 
and DABZ, was obtained in hamster than in rat hepatocytes 
(Figure 1). Kornbrust et al. (1984) recently also showed that 
BZ induced a higher DNA-repair in primary cultures of hamster 
hepatocytes than rat hepatocytes. They also reported that the 
direct alkylating agent methylmethanesulfonate (MMS) induced a 
similar DNA-repair response in rat and hamster hepatocytes. 
Therefore, it is more likely to attribute the observed greater 
DNA-repair response in the hamster hepatocytes after exposure to 
BZ, MABZ and DABZ (Figure 1), to a higher activating potential of 
the hamster hepatocytes than to differences in DNA-repair 
capacity between the rat and hamster hepatocytes. The greater 
DNA-repair response to BZ, MABZ and DABZ, in hamster hepatocytes 
in comparison with rat hepatocytes is consistent with our 
previous observation that the mutagenic- activity of these 
compounds to Salmonella typhimurium was higher in the presence of 
hamster than rat hepatocytes (Neis, 1984 and 1985b). These 
species differences are not surprising since it is known that the 
hamster liver posesses a far more effective N-acetylase, 
N-hydroxylase, N,0-acyltransferase and sulfotransferase activity 
(important steps in the metabolic activation of arylamines and 
arylamides to genotoxic products) than the rat liver (Kato, 1983; 
Morton, 1979 and 1980). Contrarily, Kennely et al. (1984) 
reported a two-fold higher DNA-adduct formation by MABZ in the 
rat than in the hamster in the liver in-vivo, as well as in liver 
slices in-vitro. 
Recently, we reported a relative low mutagenic activity of DABZ 
(compared to BZ and MABZ) towards Salmonella typhimurium TA1538 
using intact isolated rat hepatocytes as metabolizing system 
(Neis, 1985b). The present results however, show DABZ highly 
active in inducing DNA-repair synthesis in rat hepatocytes 
(Figure 1). In the Salmonella/hepatocyte assay, however, 
bacterial mutagenicity represents extra-hepatocellular appearance 
of proximate and ultimate mutagenic metabolites, whereas in the 
hepatocyte/repair assay, DNA-excision repair is an endpoint of 
genotoxic effects within the hepatocytes. The close proximity of 
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metabolic activation and the target hepatocellular DNA in the 
hepatocyte/repair assay, can be expected to increase sensitivity 
to those compounds, whose reactive intermediates are produced in 
relative low concentration and/or have very short half-lives. 
This may explain the relative higher genotoxicity of DABZ in the 
DNA-repair assay than in the Salmonella/hepatocyte assay. 
The relative small increase in DNA-repair in the guinea pig 
hepatocytes when exposed to BZ, MABZ and DABZ is consistent with 
our previous observed low mutagenicity of these compounds when 
activated by guinea pig hepatocytes (Neis, 1984 and 1985b). It 
is also consistent with the reported resistance of the quinea pig 
to the carcinogenic action of arylamines and arylamides, e.g. 
2-aminofluorene and 2-acetylaminofluorene. The observed low 
genotoxicity may be due to a low rate of N-hydroxylation (Morton, 
1979; Miller, 1964) or a high detoxification of formed 
N-hydroxy-metabolites (Razzouk, 1980) in the guinea pig 
hepatocytes. 
The results of this study again underline that differences in 
biotransformation contribute to interspecies variations in 
susceptibility to chemical carcinogens. 
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SUMMARY 
The mutagenicity of benzidine (BZ), N-acetylbenzidine (MABZ), 
NjN'-diacetylbenzidine (DABZ), 4-aminobiphenyl (4-AB) and 
2-aminoanthracene (2-AA) towards Salmonella typhimurium strain 
TA1538 was measured in the presence of isolated hepatocytes from 
dog and man. The influence of paraoxon, an inhibitor of the 
deacetylation reaction, on the mutagenicity of these compounds 
was also investigated. 
Obvious interspecies differences in the mutagenic activation of 
benzidine and its acetylated-derivatives were seen. However, 
with liver cell preparations from both species it was found that 
MABZ and DABZ were more mutagenic than BZ itself. 4-AB appeared 
to be weakly mutagenic in the presence of human hepatocytes but 
non-mutagenic with dog hepatocytes. 2-AA was highly mutagenic in 
both species. When human hepatocytes were used as the metabolic 
factor, the mutagenicity of all arylamines decreased in the 
presence of paraoxon. With dog hepatocytes, however, the 
mutagenicity of all arylamines except DABZ was enhanced in the 
presence of paraoxon. 
INTRODUCTION 
Since the development of a method for in situ perfusion of the 
liver with collagenase, isolated hepatocytes have been used 
extensively to study the biotransformation and genotoxicity of 
xenobiotic compounds. Great differences in metabolic activation 
of arylamines between animal species, are held responsible for 
the variations in susceptibility to these compounds (Irving, 
1979). Consequently, predictions about toxicity of these 
compounds to humans, based on animal research data are 
questionable. 
Carcinogenic arylamines are acetylated by most animal species. 
The acetylated-derivatives are subject to further 
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biotransformation like N-hydroxylation, (N,0)-acyltransfer or 
sulfotransfer to produce reactive electrophiles capable of 
binding covalently with cellular macroraolecules (Irving, 1979). 
Marked interspecies differences in the ability of the liver to 
act in the N-acetylation reaction of arylamines have been 
reported (Irving, 1979; Lower, 1973; Morton, 1979). Differences 
in N-acetylation are considered to be factors, capable of 
modulating susceptibility to carcinogenic arylamines (Irving, 
1979; Neis, 1984). Previous investigations demonstrated the 
great importance of the acetylation reaction in the 
biotransformation of arylamines into mutagenic products (Kennely, 
1984; Neis, 1984). It is known that most dogs have only a 
limited ability to acetylate arylamines (Bradshaw, 1955; Haley, 
1982; Irving, 1979; Lower, 1973; Poirier, 1963; Scianni, 1958) in 
contrast to man (Haley, 1982; Scianni, 1961; Troll, 1963). In 
the present study we compared the mutagenicity of five 
structurally related arylamines in the Salmonella/hepatocyte 
assay using isolated dog and human hepatocytes. Special 
attention was given to the role of the deacetylation reaction in 
the metabolic activation of these compounds. 
MATERIALS AND METHODS 
Chemicals 
BZ was purchased from Merck (Darmstadt, FRG). MABZ and DABZ were 
obtained from ICN Pharmaceuticals, Inc. (Plainview, NY, USA). 
MABZ and DABZ were purified by recrystallization (purity>97%, 
checked with HPLC). 4-AB and 2-AA and 
diethyl-p-nitrophenylphosphate (paraoxon) were from Aldrich 
Europe (Beerse, Belgium). D-Biotin, L-histidine-HCl, collagenase 
type 1, nicotinamide adenine dinucleotide phosphate disodium salt 
and glucose-6-phosphate dipotassium salt were obtained from 
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Sigma (St. Louis, Missouri, USA). Purified agar was from Difco 
Laboratories, nutrient broth No. 2 from Oxoid Ltd. (Basingstoke, 
UK). All other chemicals used were of high purity. 
Preparation of isolated hepatocytes 
The in situ two-step collagenase-perfusion technique described 
for the isolation of hepatocytes from rodent liver (Neis, 1984) 
was adapted into a procedure applicable for the isolation of dog 
and human hepatocytes. All manipulations were performed under 
sterile conditions. 
Dog hepatocytes 
Male beagle dogs, about 30 weeks old, were anesthetized with 
pentobarbital sodium (30 mg/kg) and heparinized. A branch of the 
portal vein leading to one of the minor lobes was cannulated. 
The liver lobe was pre-perfused in situ with approximately 300 ml 
saline. Then the total liver was removed from the body and 
transferred to a perfusion apparatus. Approximately 1 liter of a 
Ca2+-free HEPES buffer (pH 7.4) was pumped through the liver lobe 
at a rate of 50 ml/min, followed by 100 ml HEPES buffer (pH 7.6) 
containing 0.05% w/v collagenase. At this stage the liver lobe 
was cut loose from the rest of the liver and perfusion was 
continued with 100 ml HEPES buffer (pH 7.6) containing 0.1% w/v 
collagenase with recirculation for the period of 10 min. After 
incubation of the crude cell suspension in a shaking waterbath 
(120 rpm) at 37 oC for 30 min, filtration, gentle centrifugation 
and cellwashing, the final pellet was resuspended in a HEPES-TES 
buffer solution (pH 7.6) containing 2% albumin. The suspension 
was diluted to a density of 10 χ 10 viable cells/ml. Viability 
was about 95% as measured by trypan-blue exclusion. 
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Human hepatocytes 
The human normal liver sample was obtained from a 35 year old 
male kidney donor 3 h after he was killed in a traffic accident. 
The liver sample (a part of the left lobe, weighing app. 400 g) 
was surrounded by the hepatic capsule on all sides except for one 
cut surface. PVC-tubing (non-toxic quality) was inserted in a 
large vein on the cut surface and held in place with a ligature. 
Then approximately 1 liter Ca2+-free HEPES buffer (pH 7.4) was 
pumped through the liver at a rate of 50 ml/min. As soon as the 
perfusion was started it was observed that a great part of the 
liver sample began to blanch. After the pre-perfusion the liver 
was perfused successively with 200 ml of a HEPES buffer (pH 7.6) 
containing 0.05% w/v collagenase without recirculation, and with 
100 ml HEPES buffer (pH 7.6) containing 0.1% w/v collagenase with 
recirculation for a period of 10 min. The total yield of 
9 isolated hepatocytes was 1.2 χ 10 cells and viability was 92% as 
measured by trypan-blue exclusion. 
Salmonella/hepatocyte suspension assay 
The Salmonella/hepatocyte suspension assay was carried out as 
follows. In a shaking waterbath (210 rpm), closed sterile 
scintillation vials (20 ml), each containing 387.5 ul of 
hepatocyte suspension (10 χ 10 viable cells/ml), 0.1 ml of an 
exponential-growing culture of Salmonella typhimurium (about 2.0 
g 
χ 10 bacteria/ml) and 12.5 ul of a solution (in DMSO) of the 
compound under test, were incubated in triplicate at 37 oC for 2 
h. Next, each mixture was plated with a molten top agar 
containing only biotin (no histidine). The number of revertant 
colonies was counted after incubation at 37 oC for 48 h. 
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Analytical methods 
The cytochrome-P450 content of the isolated hepatocytes was 
measured with the cytochrome-P450 CO-difference spectra after 
reduction with sodium dithionite according to the method of Omura 
and Sato (1964). Prior to the measurement of the 
cytochrome-P450, the hepatocyte suspension was sonicated twice 
for 20 sec with an interval of 30 sec in an MSE Ultrasonic 
Disintegrator (100W) at maximal energy. During this step the 
suspension was cooled on ice. 
Cellular protein content was assayed by the Coomassie Brilliant 
Blue method , using 0.1N NaOH to lyse the cells (Godstadt, 1982). 
The cells were previously washed with saline to remove 
contaminants (e.g. albumin) in the suspension buffer. Bovine 
serum albumin was used as a standard. 
RESULTS 
Cell size, protein- and cytochrome P-450 content 
For both species cell size, protein- and cytochrome-P 450 content 
of the isolated hepatocytes were determined (Table I). 
The data in Table I clearly show that the human hepatocytes 
contain less protein and cytochrome P-450 than the dog 
hepatocytes. 
Mutagenicity of BZ, MABZ, DABZ, 4-AB and 2-AA 
Figure 1 shows the mutagenicity of BZ, MABZ, DABZ, 4-AB and 2-AA 
towards Salmonella typhimurium strain TA1538 after metabolic 
activation with isolated hepatocytes from dog and man. 
Great interspecies differences in the mutagenic potency of BZ, 
MABZ and DABZ were seen. These three compounds revealed a 
relatively high mutagenicity after activation with human 
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TABLE I 
CELL SIZE, PROTEIN AND CYTOCHROME P-450 CONTENT OF ISOLATED DOG 
AND HUMAN HEPATOCYTES 






17-21 960 ± 23 
10 cells 
210 ± 10 
Man 17.7 16-19 500 + 16 94 ± 2 
a) Values obtained by microscopic measurement using a calibrated grid. 
b) Values are the means ( ± S.E.M. ) of determinations in triplicate. 
TABLE II 
INFLUENCE OF PARAOXON ON THE MUTAGENICITY OF BZ, MABZ, DABZ, 4-AB AND 





















(10"4M) BZ  'M 56 
MABZ (10" M) 40 










Values representing relative mutagenicity (% of control) are the means of 
determinations in triplicate. 
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h e p a t o c y t e s , w h e r e a s w i t h dog h e p a t o c y t e s BZ was non-rautagenic, 
MABZ and DABZ were o n l y weak ly m u t a g e n i c . With dog h e p a t o c y t e s 
DABZ showed a h i g h e r m u t a g e n i c a c t i v i t y than MABZ, whereas w i t h 
t h e human c e l l s MABZ was s l i g h t l y more m u t a g e n i c than DABZ. 
However, in both c a s e s MABZ and DABZ were more m u t a g e n i c than BZ 
i t s e l f . 
4-AB showed a low m u t a g e n i c a c t i v i t y w i t h human h e p a t o c y t e s but 
was non-mutagen ic w i t h dog h e p a t o c y t e s . No o b v i o u s i n t e r s p e c i e s 
d i f f e r e n c e s in t h e m u t a g e n i c p o t e n c y of 2-AA were o b s e r v e d . I t 
appeared t o be h i g h l y m u t a g e n i c in t h e p r e s e n c e of h e p a t o c y t e s 
from e i t h e r s p e c i e s . 
Concentration ( ^ М ) (діМ) 
Fig. 1. Mutagenicity of BZ(Ο) , ΜΑΒΖ(Δ), DABZ(D) , 4-АЬ(·) and 2-AA(M) towards 
Salmonella typhimurium TAI 538 a f t e r metabolic a c t i v a t i o n with i n t a c t 
hepatocytes from man and dog. Values are the means of determinat ions in 
t r i p l i c a t e . 
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Influence of paraoxon 
The effects of paraoxon - an inhibitor of the deacetylation 
reaction- on the mutagenicity of the arylamines, in the presence 
of human and dog hepatocytes, are shown in Table II. 
With human hepatocytes the mutagenicity of all arylamines was 
decreased in the presence of paraoxon. The decrease in 
mutagenicity was higher with 10 M paraoxon than with 10 M. 
This inhibitory effect on the mutagenicity of BZ and its 
acetylated-derivatives was in the order DABZ > MABZ > BZ. 
The mutagenic activity of 2-AA was only weakly influenced. 
On the contrary, with dog hepatocytes the mutagenicity of all 
arylamines except DABZ was enhanced in the presence of paraoxon. 
It should be noted, that the addition of paraoxon had no 
deleterious effect on the bacteria, as was concluded from the 
absence of any influence on bacterial growth. It was also 
ensured that hepatocellular viability was not influenced by the 
presence of paraoxon in these concentrations. An inhibitory 
effect on microsomal oxidizing capacity at the concentration used 
was also virtually absent. 
DISCUSSION 
Dog and human hepatocytes were isolated, in a viable state, using 
a modification of the collagenase perfusion technique, generally 
employed for the isolation of rodent hepatocytes. The mutagenic 
activation of the tested arylamines proceeded more effectively in 
the presence of human hepatocytes than with dog hepatocytes, 
although the cells of the dog contained more cytochrome-P 450. 
For most species, including man, it seems that the rate of 
N-acetylation is greater than the deacetylation rate (Haley, 
1982; Irving, 1979; Lower, 1973; Morton, 1979; Scianni, 1961; 
Troll, 1963). However, in the dog, a species being deficient in 
N-acetyltransferase activity (Bradshaw, 1955; Clayson, 1959; 
Haley, 1982; Irving, 1979; Lower, 1973; Poirier, 1963; Scianni, 
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1958) but having a high deacetylation capacity towards acetylated 
arylamines (Clayson, 1959), deacetylation predominates. This 
phenomenon may partly account for the observed non-mutagenicity 
of BZ and the low mutagenicity of MABZ and DABZ in the presence 
of dog hepatocytes, and the relatively high mutagenicity of all 
three compounds with human hepatocytes. When in the dog 
hepatocytes the deacetylation reaction is inhibited by paraoxon, 
the mutagenicity of all arylamines except DABZ increased (Table 
II). This may indicate that dog hepatocytes are able to act in 
the N-acetylation of arylamines but that due to a high 
deacetylation rate the nett production of N-acetylated 
metabolites is negligible. The substantial decrease in 
mutagenicity of DABZ due to paraoxon in both species, indicates 
that deacetylation is an essential step in the mutagenic 
activation of this diacetylated derivative. On the other hand, 
in human hepatocytes paraoxon decreased the mutagenicity of the 
tested arylamines. This indicates that in this species apart 
from acetylation also deacetylation is involved in the generation 
of mutagenic products. Brouns et al. (1982) already presented 
data which were in favour of the role of the N-acetylation and 
deacetylation in the metabolic activation of BZ into mutagenic 
products in isolated rat hepatocytes. From the present data 
together with those obtained from studies mentioned above, we 
suggest that factors affecting the balance between acetylation 
and deacetylation may play an essential role in determining 
tissue and species susceptibility to arylamme carcinogenesis. 
BZ was highly mutagenic and 4-AB was weakly mutagenic after 
activation with human hepatocytes, whereas both were 
non-mutagenic with dog hepatocytes (Figure 1). These 
observations are well compatible with the report that BZ and 4-AB 
are known potent human urinary bladder carcinogens in man (Case, 
1954; Clayson, 1976; Scott, 1952; Zavon, 1973), whereas they are 
at best weak urinary bladder carcinogens in the dog (Deichmann, 
1965; Spitz, 1950). The observed mutagenicity of BZ and 4-AB 
after metabolic activation with human hepatocytes indicates that 
the liver may contribute to the generation of carcinogenic 
metabolites for bladder cancer initiation in man. Phillipson et 
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al. (1983) recently showed that BZ was almost non-mutagenic 
towards Salmonella typhimurium TA1538 after metabolic activation 
with a human liver homogenate preparation (S9-mix) in the 
Ames-assay. On the contrary, using intact human hepatocytes we 
found BZ highly mutagenic. These findings again emphasize the 
usefulness of intact hepatocytes instead of subcellular liver 
fractions in studies of mutagenic activation. It is generally 
believed that the existence of interspecies differences in 
metabolic activation of genotoxic agents is the main problem in 
extrapolating animal research data to humans. Comparative 
studies with isolated hepatocytes from different species, 
including man, may be most helpful making these problems more 
comprehensible. 
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SUMMARY 
The mutagenicity of 10 known genotoxic compounds, of several 
chemical classes, was measured in Salmonella typhimurium 
mutagenicity assays comprising isolated human hepatocytes or 
human 9000 xg liver supernatant (S9) from four different 
individuals, as activating system. 
The mutagenic activity of several compounds as determined with 
the Salmonella/hepatocyte suspension assay showed obvious 
differences as compared to the values obtained in the 
Salmonell/S9 plate assay. For instance, the mutagenic activity 
of benzidine (BZ) , dimethylnitrosamine (DMN) and 
diethylnitrosamine (DEN) appeared to be much higher in the 
hepatocyte assay than in the S9 assay. However, 2-aminofluorene 
(2-AF) and 2-acetylaminofluorene (2-AAF) were activated more 
effectively to mutagens in the S9 assay than in the hepatocyte 
assay. 2-AF was slightly more mutagenic than 2-AAF in the 
hepatocyte assay, whereas it was far more mutagenic than 2-AAF in 
the S9 assay. DMN was found more mutagenic than DEN in the 
hepatocyte assay, whereas in the S9 assay DEN appeared to be 
slightly more mutagenic. Furthermore, great inter individual 
differences in the metabolic activation of certain compounds, 
e.g. BZ and DMN, were observed in the hepatocyte suspension 
assay, whereas these variations were less evident in the S9 plate 
assay. 
Comparison of the mutagenicity data obtained with the human liver 
preparations, with those obtained with rat liver preparations, 
showed great interspecies differences in the capacity to activate 
certain chemicals to mutagens. 
The use of human liver preparations, in particular isolated human 
hepatocytes, may be of great value in studies on inter- and 




After Ames et al. (1975) had shown that the Salmonella/microsome 
assay was capable of identifying a large proportion of 
carcinogens, this test system has become a well developed and 
established in vitro mutagenicity assay, which is now widely used 
in laboratories throughout the world. In this short-term test a 
9000 xg supernatant fraction (S9) from rat liver is applied to 
mediate metabolism of the test chemicals to mutagenic products. 
Several studies (Bartsch, 1983; Bigger, 1980; Bos, 1983; Greim, 
1981; Langenbach, 1983; Neis, 1984; Jones, 1983) however, have 
indicated that S9 liver preparations may not properly represent 
the in vivo activation and deactivation processes, whereas 
preparations of intact hepatocytes are a better substitute in 
this respect. 
It has also become evident that marked differences exist between 
species, strains and sexes in the metabolism and susceptibility 
to carcinogens (Kato, 1979; Motulsky, 1982; Streissinger, 1983; 
Williams, 1978) 
In regard of the estimation of genotoxic risks to humans, the 
interpretation of data obtained from current in vitro 
mutagenicity assays (using rodent S9 fractions) is not only 
hampered by a difference between in vitro and in vivo conditions 
but also by interspecies variations. 
We have recently described an isolation technique to obtain 
hepatocytes from rodent species (Neis, 1984 and 1985b). By 
modifying this technique into a procedure for isolation of 
hepatocytes from larger species including man, human hepatocytes 
could be isolated in a viable state (Neis, 1985a). The isolated 
human hepatocytes appeared to activate certain arylamines and 
arylamides effectively to products mutagenic to Salmonella 
typhimurium (Neis, 1985a). Obvious interspecies differences were 
observed in the mutagenic activation of these compounds between 
rodent, dog and human hepatocytes (Neis, 1984, 1985a and 1985b). 
In the present study the mutagenicity of 10 known pregenotoxic 
agents, including some polycyclic arylhydrocarbons, 
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N-nitrosamines and arylamines (compounds known to be 
activated/deactivated via different pathways), were studied in 
the Salmonella mutagenicity assay using intact human hepatocytes 
and human liver S9 preparations as metabolizing system. The 
obtained results were compared with results previously obtained 
with rat liver preparations. 
MATERIALS AND METHODS 
Chemicals 
Chemicals were obtained from the following sources: BZ from 
Merck (Darmstadt, FRG); MABZ and DABZ were from ICN 
Pharmaceuticals, Inc. (Plainview, NY, USA) and were purified by 
recryatallization (purity>97%, checked with HPLC); 2-AF, 2-AAF, 
DMN and B(a)P from Aldrich Europe (Beerse, Belgium); DEN from 
Aldrich Chemical Co. Inc. (Milwaukee, USA); CP and HEH from 
Asta (Brackwede, FRG); 7,12-DMBA from Eastman Kodak Company; 3-MC 
from Koch-Light Laboratories Ltd. Collagenase (from Clostridium 
histolyticum) was obtained from Boehringer (Manheim, FRG) 
Purified agar was from Difco Laboratories, nutrient broth No. 2 
from Oxoid Ltd. (Basingstoke, Great Britain). All other 
chemicals used were of high purity. 
Subjects 
In Table I data about age and sex of the four subjects are shown. 
Subject 1, was known to be a heavy drinker. The liver histology 
of this person showed some fibrosis with fatty changes and 
inflammatory cell infiltrates consistent with an alcoholic liver 
disease. 
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Preparation of isolated hepatocytes 
Postmortal human liver tissues were obtained from kidney donors 
and human hepatocytes were isolated by a two-step perfusion 
technique, modified from that described for the isolation of 
rodent hepatocytes (Neis, 1984 and 1985b). All manipulations 
were performed under sterile conditions. 
After removal from the body, the liver samples were perfused by 
syringe with cold saline to remove most of the blood, and 
subsequently placed in cold saline. Then the liver sample was 
kept on ice until the isolation procedure could be started 
(approximately 2-3 hours). 
The liver sample (a part of the left lobe, about 250-400 g) was 
surrounded by the hepatic capsule on all sides except for one cut 
surface. PVC-tubings (non-toxic quality) were inserted in large 
veins on the cut surface and held in place with ligatures. Then 
approximately 2 liters of Ca2+-free HEPES buffer (pH 7.4), 
containing 0.5 mM EGTA, was pumped through the liver sample at a 
total rate of 150-200 ml/min (50 ml/min per tubing). As soon as 
the perfusion was started it was observed that a great part of 
the liver sample began to blanch. After the pre-perfusion, the 
liver sample was perfused successively with 200 ml of a HEPES 
buffer (pH 7.6), containing 0.05% w/v collagenase and 5mM CaC12 
with recirculation for 10 min, and with 100 ml HEPES buffer 
(pH 7.6) containing 0.1% w/v collagenase and 5 mM CaC12 with 
recirculation for about 20 min. The buffers were maintained at 
37 oC and continuously gassed with 02 (medical quality). After 
the collagenase perfusion, the liver tissue was gently teared 
apart. The loosened mass was passed through 250 uM nylon filter. 
The filtrate was cooled on ice and then centrifuged at 40 xg for 
5 min at 4 oC. The resultant pellet was resuspended in cold 
HEPES-TES buffer solution (pH 7.6) containing 2% albumine 
(incubation buffer), and recentrifuged. The pellet was 
resuspended in cold incubation buffer and incubated in a shaking 
waterbath (120 rpm) at 37 oC for 15 min. Then the cell 
suspension was passed through 100 uM nylon filter. Then the 
viability of the hepatocytes was determined by trypan-blue 
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exclusion. The hepatocyte suspension was diluted to a density of 
10 χ 10 viable cells/ml. 
Preparation of S9mix 
The human liver S9mix was prepared as follows. A part of the 
human liver sample (obtained from the same liver sample, as would 
be used for the isolation of hepatocytes) was cut into small 
pieces and immediately placed in liquid nitrogen. After 10 min 
the pieces were transferred to the freezer (-80 oC) and stored 
until used. The froozen liver pieces were then minced with a 
Waring Blendor mixer and subsequently three volumes of ice cold 
0.15 M KCl were added and the mixture was homogenized in a 
Elvehjem-Potter homogenizer with a Teflon pestle. The homogenate 
was centrifugad at 9000 xg for 20 min at 4 oC. The supernatant 
(S9) was transferred into cryopreservation vials and placed in 
liquid nitrogen and subsequently stored at -80 oC. All 
manipulations were performed under sterile conditions. The S9mix 
used for the mutagenicity assay contained 0.1 ml S9 per ml. The 
concentration of NADP and G-6-P in the S9mix was 4 mM and 5 mM, 
respectively. 
Mutagenicity assays 
Salmonella/hepatocyte suspension assay 
The Salmonella/hepatocyte assay was carried out as follows. In a 
shaking waterbath (210 rpm), closed sterile scintillation vials 
(20 ml), each containing 387.5 ul of hepatocyte suspension 
(10 χ 10 viable cells/ml), 0.1 ml of an exponential-growing 
g 
culture of Salmonella typhimurium (about 2.0 χ 10 bacteria/ml) 
and 12.5 ul of a solution of the compound under test, were 
incubated in triplicate at 37 oC for 2 h. DMN, DEN, and CP were 
dissolved in saline and sterilized by filtration. The other test 
compounds were dissolved in dimethylsulfoxide,- The mutagenicity 
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of DMN and DEN appeared effectively inhibited when dissolved in 
diraethylsulfoxide instead of saline (unpublished data). After 
incubation, each mixture was plated with a molten top agar 
containing biotin (no histidine). The number of revertant 
colonies was counted after 48 h of incubation at 37 oC. 
Salmonella/hepatic S9 plate assay 
The Salmonella/S9mix plate assay was performed according to the 
assay described by Ames et al. (1975) for rat liver S9mix, 
except that exponential growing cultures of Salmonella 
typhimurium strains hisG46, TA1535, TA1538 and TA100 were used. 
We used Oxoid nutrient broth instead of Difco nutrient broth . 
The concentrations of the test substances in both mutagenicity 
assays, were chozen so that the concentration in the top agar 
layer in the S9 plate assay approximately equals the 
concentration in the hepatocyte suspension assay. 
Cytochrome-P450 content 
The cytochrome-P450 content of the isolated hepatocytes was 
measured with the cytochrome-P450 CO-difference spectra after 
reduction with sodium dithionite according to the method of Omura 
and Sato (1964). Prior to the measurement of the cytochrome-P450 
content of the isolated hepatocytes, the hepatocyte suspension 
was sonicated twice for 20 sec with an interval of 30 sec in an 
MSE Ultrasonic Disintegrator (lOOW) at maximal energy. During 
this step the suspension was cooled on ice. 
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Measurement of the metabolism of benzo(a)pyrene by rat and human 
liver S9 
The metabolism of B(a)P by rat and human liver S9mix was measured 
by use of high pressure liquid chromatographic determination of 
ether-soluble metabolites of B(a)P. The rat liver S9 was 
prepared from the pooled livers of four non-induced rats, as 
described by Ames et al. (1975). The S9 was stored at -80 oC. 
The rat liver S9mix contained NADP (4mM), G-6-P (5mM) and 0.1 ml 
S9 per ml. B(a)P was incubated with rat or human liver S9mix as 
follows. In a shaking waterbath (210 rpm) closed vials (inner 
diameter 30 mm), each containing 1.95 ml S9mix and 50 ul of a 
solution of B(a)P in dimethylsulfoxide (final concentration of 
В(a)Ρ in the reaction mixture was 25 uM) were incubated at 37 oC 
for 2 h. After incubation each mixture was cooled on ice. Then 
the 2 ml mixtures were extracted with 2x5 ml ether. The organic 
layers were collected and evaporated to dryness at 30 oC under a 
constant flow of nitrogen. The residue was dissolved in 2 ml 
methanol and HPLC-analysed, according to a procedure described by 
Jongeneelen et al. (1985). 
RESULTS 
Cytochrome-P450 content and viability of isolated human 
hepatocytes 
Table I shows the cytochrome-P450 content and the viability of 
the isolated human hepatocytes. Great differences in the 
cytochrome-P450 content of the isolated hepatocytes were observed 
6 
between the four subjects, ranging from 85 to 360 pmol/10 cells. 
The viability of the isolated hepatocytes was in these four cases 
about 80%, as judged with trypan-blue exclusion. 
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TABLE I 
CYTOCHROME-P450 CONTENT AND VIABILITY OF ISOLATED HUMAN HEPATOCYTES 
S u b j e c t Age Sex Cytochromo-P450 c o n t e n t V i a b i l i t y 
( pmol / 10 6 c e l l s ) ( % ) ' 
I 
I I 










IV 51 M 360 80 
P e r c e n t of c e l l s e x c l u d i n g Trypan-Blue ( 0 .12 % w/v ) . 
Mutagenicity in the Salmonella/hepatocyte suspension assay and 
Salmonella/hepatic S9 p l a t e assay 
Arylamines 
The mutagenicity of BZ, 2-AF and 2-AAF towards Salmonella 
typhimurium s t r a i n TA1538 i s shown in Figure l a . These r e s u l t s 
indicate that BZ i s far more e f fec t ive ly act ivated to mutagenic 
products in the hepatocyte assay than in the S9 assay. Obvious 
in ter indiv idual differences in mutagenic ac t iva t ion of BZ are 
seen in the hepatocyte assay, whereas these differences are 
almost absent in the S9 assay. 2-AF and 2-AAF are act ivated less 
ef fect ive with hepatocytes from subject 3 compared with 2 and 4, 
whereas in the S9 assay the S9 of subject 3 appeared more ac t ive 
than 2 and 4. For 2-AF inter individual differences are less 
pronounced in the hepatocyte assay, whereas they are obvious in 
the S9 assay. In both assays these var ia t ions are less obvious 
for 2-AAF. Remarkable is the high mutagenicity of 2-AF and 2-AAF 
in the S9 assay at r e l a t i v e very low concent ra t ions . 
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Revertants (log scale) 
Fig. la. Mutagenicity of BZ, 2-AF and 2-AAF towards Salmonella typhimurium 
stram TAI538, in the Salmonella/hepatocyte suspension assay (A) and m the 
Salmonella/hepatic S9 plate assay (B). Liver preparations of person 1(·), 
2(A), 3 (•) and 4(0). Values represent the mean revertant-number of triplicate 
determinations. Note the number of revertants is in log-scale. 
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Fig. lb. Mutagenicity of В(a)Ρ, 3-MC and 7,12-DMBA towards Salmonella typhi-
munum strain TA100, in the Salmonella/hepatocyte suspension assay (A) and in 
the Salmonella/hepatic S9 plate assay (B). Liver preparations of person 1(·), 
2(A), 3(•) and 4(0). Values represent the mean revertant-number of triplicate 
determinations. Note the number of revertants is in log-scale. 
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Revertants (log scale) 
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Fig. 1c. Mutagenicity of DMN and DEN towards Salmonella typhimurium stram 
hisG46, m the Salmonella/hepatocyte suspension assay (A) and in the Salmo­
nella/hepatic S9 plate assay (B). Liver preparations of person 1(·), 2(a), 
3(•) and 4(0). Values represent the mean revertant-number of triplicate 
determinations. Note the number of revertants is in log-scale. 
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Fig. Id. Mutagenicity of CP and HEH towards Salmonella typhimurium strain 
TAI 535, in the Salmonella/hepatocyte suspension assay (A) and in the Salmo­
nella/hepatic S9 plate assay (B). Liver preparations of person 1(·), 2(a), 
3(•) and 4(0). Values represent the mean revertant-number of triplicate 
determinations. Note the number of revertants is in log-scale. 
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Polycyclic arylhydrocarbons 
The mutagenicity of benzo(a)pyrene (B(a)P), 3-methylcholanthrene 
(3-MC) and 7,12-dimethylbenzanthracene (7,12-DMBA) towards 
Salmonella typhimurium strain ТАІОО are presented in Figure lb. 
For subject 2 and 4 the three PAH's were only tested at a 
concentration of 100 uM. All three PAH's showed a relative low 
mutagenic activity in both assays with liver preparations of all 
the four individuals. Remarkable is the low mutagenic activity 
of the three PAH's in the hepatocyte assay for subject 3 compared 
with 1, 2 and 4, whereas in the S9 assay 3 appeares the more 
effective in activating the PAH's. 
N-nitrosamines 
The mutagenicity of DMN and DEN towards Salmonella typhimurium 
hisG46 is shown in Figure 1c. DMN was highly mutagenic in the 
hepatocyte suspension assay, whereas its mutagenicity was poorly 
detected in the S9 plate assay. Also great inter individual 
differences in the mutagenic activation of DMN were seen in the 
hepatocyte assay, whereas these differences were absent in the S9 
assay. DEN appeared to be highly mutagenic in both assays. 
Obvious is the low activating potency of subject 3 compared with 
1, 2 and 4 in the hepatocyte assay, whereas this difference is 
less pronounced in the S9 assay. 
Cyclophosphamide 
The mutagenicity of CP in both assays is presented in Figure Id. 
The mutagenicity was determined with Salmonella typhimurium 
strain TA1535. CP showed mutagenic activity in both assays. 
However, again inter individual differences were observed in the 




The mutagenicity of HEH is presented in Figure Id. The 
mutagenicity of HEH in the hepatocyte assay was only tested with 
hepatocytes of subject 1, 3 and 4. HEH was mutagenic in both 
assays. However no inter individual differences were seen in the 
S9 assay, whereas these variations were clear in the hepatocyte 
assay. 
Comparison of mutagenic activation capacities between the human 
and rat liver preparations 
Table II summarizes some remarkable differences in the mutagenic 
activity of pregenotoxic agents after activation with human liver 
preparations on the one hand, and rat liver preparations on the 
other, using the SaImonella/hepatocyte and the Salmonella/hepatic 
S9 assays. The results with the rat liver preparations were 
partly derived from our previous reports (Bos, 1983; Neis, 
1985c) . 
The arylamines BZ, 2-AF and the arylamide 2-AAF appeared to be 
activated far more effectively to mutagens by human hepatocytes 
than by rat hepatocytes. 
In the S9 plate assay 2-AF and 2-AAF were found to be far more 
mutagenic when human liver S9 instead of rat liver S9 was used. 
On the contrary, the polycyclic arylhydrocarbons, in particular 
B(a)P, were more effectively activated to mutagens, when rat 
liver S9 was used instead of human liver S9. 
For other compounds, like CP, DMN and DEN, no such obvious 
differences in mutagenic activities were found with rat liver 
preparations on the one hand, and human liver preparations on the 
other, in both mutagenicity assays (data not shown). 
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TABLE II 






(25 UM) TA1538 
(25 UM) ΤΑ153Θ 
(25 UM) TAI538 
hist revertants per plate 











103 ± 30 
67 ± 9 
28 ± 5 
Strain 
2-AF (2.5 nmol/pl) ΤΑ153Θ 
2-AAF (2.5 nmol/pl) TAI 538 
В(a)Ρ (65 nmol/pl) TA100 
3-MC (65 nmol/pl) TA100 
7,12-DMBA (65 nmol/pl) TA100 
hist revertants per plate 






























* Isolated intact hepatocytes, or liver S9-fractions from four different 
subjects. 
** Values represent the mean ± S.E.M. of four separate experiments with 
hepatocyte preparations of different rats. 
*** Values represent the mean revertant number of triplicate plates. 
The S9-fraction was derived from the pooled livers of four rats. 
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Comparison of B(a)P hydroxylation by human and rat liver 
59 preparations 
The question rises whether there is a relationship between the 
species-dependent difference in mutagenic activation (Table II) 
and hepatic enzyme activity in vitro. 
This was examined for B(a)P. Figure 2 shows the metabolism of 
B(a)P by human and rat liver S9mix, using HPLC determination of 
ether-soluble metabolites. In Figure 2 only a representative 
HPLC-profile (obtained with the S9mix of subject 1) of the four 
examined subjects is shown. It was observed that non-induced rat 
liver S9 was far more active in metabolizing B(a)P to 
ether-soluble metabolites, than the human S9 liver preparations. 
Units of fluorescence 
B(a)P 
Хек =265 η m 
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Fig. 2. Comparison of the metabolism of В(a)Ρ by rat and human liver S9mix, 
using high pressure liquid chromatographic determination of ether-soluble 
metabolites. Note quantitative differences between rat and man. 
ЭЗ 
For instance, a much higher formation of 3-0H-B(a)P and 
9-0H-B(a)P with rat liver S9 was found (Figure 2). In agreement 
to this a lower amount of unmetabolized B(a)P was found after 
incubation with rat liver S9 compared with the human liver S9 
(Figure 2). 
DISCUSSION 
In this study, obviously divergent mutagenic values were obtained 
for the compounds tested, with the human hepatocyte suspension 
assay on the one hand, and the human S9 plate assay on the other 
(Figure 1). We recently showed for BZ, 4-AB, 2-AA and DMN, by 
comparison between mutagenicity values obtained with suspensions 
of intact rodent hepatocytes and S9 prepared of these cells under 
comparable experimental conditions, that the observed divergent 
mutagenicity values with the hepatocyte suspension assay compared 
to the S9 plate assay, are rather due to intrinsic differences in 
the activating potential of S9 versus hepatocytes than to 
methodological differences (Bos, 1983; Neis, 1984). BZ, DMN and 
DEN appeared to be far more mutagenic in the hepatocyte assay 
than in the S9 assay (Figure la,c). Phillipson et al. (1983) 
recently also found that BZ was only weakly mutagenic to 
Salmonella typhimurium TA1538 after metabolic activation with a 
human S9 liver preparation. These findings are consistent with 
our previous report that intact rodent hepatocytes are able to 
activate BZ to mutagenic products, whereas the S9 preparation of 
these cells was only able to activate BZ when the S9 was 
supplemented with acetyl-CoA, the cofactor for the N-acetylation 
reaction (Neis, 1984). We therefore suggest that the lack of 
N-acetylation in the S9 is responsible for the relative low 
mutagenicity of BZ in the human liver S9 plate assay, as compared 
with the human hepatocyte suspension assay. 
Glowinski et al. (1978) have reported the existence of the 
genetic N-acetylation polymorphism of arylamine carcinogens, e.g. 
BZ and 2-AF, in human liver preparations. The observed 
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inter individual diffferences in the mutagenic activation of BZ 
(Figure la) may be a reflection of differences in N-acetylation 
capacity of the isolated hepatocytes of these individuals. We 
recently showed that N-acetylbenzidine (MABZ) and 
Ν,Ν'-diacetylbenzidine (DABZ) are more mutagenic than BZ itself, 
when activated by human hepatocytes (Neis, 1985a). Therefore 
differences in N-acetylation capacity of the hepatocytes, e.g the 
formation of the more mutagenic MABZ and DABZ, will influence the 
mutagenicity of BZ. The present results show that the 
mutagenicity of 2-AF and its acetylated derivative 2-AAF is 
almost equal after activation with intact hepatocytes 
(Figure la). Therefore differences in N-acetylation capacity 
between hepatocytes from the four individuals will not influence 
the mutagenicity of 2-AF or 2-AAF as obvious as BZ. 
Inter individual differences were also found for other compounds 
e.g. DMN, DEN, CP and HEH in the hepatocyte assay (Figure lc,d). 
Inter individual variations in the activation of genotoxic 
compounds by human liver preparations have also been reported by 
other investigators (Dybing, 1979; Felton, 1984; McManus, 1983; 
Moore, 1984; Strom, 1982 and 1983). The observed inter individual 
variations may reflect differences in hepatic drug metabolizing 
enzymes, that are known to be affected by genetic factors, sex, 
age, and differences in exposure to inducers like, alcohol, 
smoking-habbits, diet etc. Obvious is the relative high 
mutagenic activating capacity of the hepatocytes of subject 1 
(Figure 1). This person was known to be an heavy drinker. We 
have recently shown that hepatocytes isolated from rats 
pretreated with ethanol, converted certain premutagens more 
effectively to mutagenic products than hepatocytes from control 
rats (Neis, 1985c). 
Also obvious inter individual differences in the cytochrome-P450 
content of the isolated human hepatocytes were observed ranging 
from 85 to 360 pmol/ 10 cells (Table I). Dybing et al. (1979) 
and Strom et al. (1982) have also reported inter individual 
variations in the cytochrome-P450 content of human liver 
preparations. Singer and Grundberger (1983), reported that 
investigations on cytochrome-P450 from human liver have shown, 
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that fractions isolated from different individuals have 
significant different subunit molecular weights. These 
investigations also showed, that human cytochromes-P450 forms a 
family of isoenzymes that are distinct from the cytochromes P-450 
isolated from experimental animals. 
The mutagenicity data of several compounds mediated by human 
hepatocytes or S9 were compared with those obtained with rat 
liver preparations. Remarkable differences in the mutagenicity 
of several compounds were seen after activation with rat liver 
preparations on the one hand, and human liver preparations on the 
other (Table II). For instance 2-AAF appeared far more 
effectively activated to mutagenic products by human hepatocytes 
or S9, than by rat liver preparations. This may be a reflection 
of the reported much higher N-hydroxylation of 2-AAF by human 
than by rat liver cytochromes-P450 (Boobis, 1984). Felton et al. 
(1984) have reported that human liver microsomes were far more 
efffective in the cytochrome-P448 dependent activation of certain 
mutagens in cooked ground beef than microsomes from non-induced 
rat or mouse liver. Recently, Beaune et al. (1985) reported 
that the arylamines 2-AA and 2-AF were more mutagenic in the 
presence of human liver preparations than rat liver preparations 
in the Ames-assay. 
In contrast, for B(a)P a much lower mutagenicity was observed 
with human liver S9 compared with rat liver S9 (Table II). This 
may be due to the higher activating capacity of the rat liver S9. 
Non-induced rat liver S9 appeared to be far more active in 
metabolizing B(a)P to ether-soluble metabolites, than the human 
liver S9 (Figure 2). A much greater formation of 3-0H-B(A)P, a 
metabolite reported as marker for the mono-oxygenase activity, an 
essential step in the metabolic activation of B(a)P to genotoxic 
products, was observed with rat liver S9 (Figure 2). Beaune et 
al. (1985), reported that the polycyclic arylhydrocarbon 3-MC 
was less mutagenic in the presence of human than rat liver S9 in 
the Ames-assay. Apart from differences in mutagenic activation 
between rat and human liver preparations, for some compounds, 
e.g. CP, DMN and DEN great similarities between the rat and 
human liver preparations were found (data not shown, see for 
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comparison Bos et al. 1983 and Neis et al. 1985b). 
The observed differences in the ability to activate various 
mutagens between cellular and subcellular liver preparations on 
the one hand and between man and rat on the other, indicates that 
critical toxification or detoxification pathways may easily be 
overlooked in studies comprising rat S9 liver preparations only. 
Application of isolated human hepatocytes can be valuable to 
obtain more insight in this problem. 
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SUMMARY 
This paper describes some striking differences between isolated 
monkey and human hepatocytes in their capacity to activate some 
known genotoxic agents to products mutagenic towards Salmonella 
typhimurium. 
Isolated monkey hepatocytes, in contrast to human hepatocytes, 
appeared to activate benzidine (BZ), N-acetylbenzidine (MABZ), 
Ν,Ν'-diacetylbenzidine (DABZ), 2-aminofluorene (2-AF) and 
2-acetylaminofluorene (2-AAF) poorly. With monkey hepatocytes BZ 
was slightly more mutagenic than DABZ, whereas with human 
hepatocytes DABZ was more active than BZ. N-nitrosodimethylamine 
(DMN) and N-nitrosodiethylamine (DEN) were also found to be 
poorly mutagenic when activated by monkey hepatocytes, unlike the 
turnan hepatocytes. However, the polycyclic arylhydrocarbons 
benzo(a)pyrene (B(a)P) and 7,12-dimethylbenzanthracene 
(7,12-DMBA) were highly active in the presence of monkey 
hepatocytes, unlike the human hepatocytes. A metabolic study 
showed that monkey liver preparations seem to possess a higher 
mono-oxygenase activity towards B(a)P than human liver 
preparations. 
INTRODUCTION 
During the last few years isolated hepatocytes have been 
increasingly used in combination with Salmonella typhimurium to 
study the potential genotoxicity of suspected chemicals (Bos, 
1983; Langenbach, 1983; Malavielle, 1983; Neis, 1984 and 
1985a,b,c; Rumruen, 1984). The Salmonella/hepatocyte assay 
combines intact eel metabolism (in a cell type with the broadest 
capability to metabolize foreign compounds) with bacterial 
mutagenicity as endpoint for genotoxic activity. 
We recently reported substantial interspecies differences between 
isolated rat, dog and human hepatocytes in their capacity to 
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activate certain chemicals to mutagens (Neis, 1984 and 
1985a,b,c). The question arises whether such differences also 
exist between liver cells from primate species. 
This paper presents a comparison of the mutagenicity of some 
known genotoxic agents measured towards Salmonella thyphimurium 
after metabolic activation by isolated hepatocytes of monkey 
(Macaca fascicular is) and man. 
MATERIALS AND METHODS 
Chemicals 
Chemicals were obtained from the following sources: BZ from 
Merck (Darmstadt, FRG); MABZ and DABZ were from ICN 
Pharmaceuticals, Inc. (Plainview, NY, USA) and were purified by 
recrystallization (purity>97%, checked with HPLC); 2-AF, 2-AAF, 
DMN, B(a)P from Aldrich Europe (Beerse, Belgium); DEN from 
Aldrich Chemical Co. Inc. (Milwaukee, USA); 7,12-DMBA was from 
Eastman Kodak Company. Collagenase (from Clostridium 
histolyticum) was from Boehringer (Mannheim, FRG). All other 
chemicals used were of high purity. 
Preparation of isolated hepatocytes 
Monkey hepatocytes 
The monkeys used for the isolation of hepatocytes were all male 
monkeys, and all were about fourtheen years old except monkey I 
who was about seven years old. 
The isolated monkey hepatocytes were prepared under sterile 
conditions with a two-step collagenase perfusion technique 
according to the procedure previously described for the isolation 
of dog hepatocytes (Neis, 1985a), with slight modifications. 
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Monkeys (Macaca fascicular is), were anesthesized and heparinized. 
The portal vein was cannulated, the bile duct ligatured, 
whereafter the liver was perfused in situ with 200 ml of saline 
so that the liver appeared to blanch totally. Then the liver was 
removed from the body and transferred to a perfusion apparatus. 
Approximately 2 liters of a Ca2+-free HEPES buffer (pH 7.4) 
containing 0.5 mM EGTA, was pumped through the liver at a rate of 
100-150 ml/min. Next, 200 ml of HEPES buffer (pH 7.6) containing 
Ca2+ (5 mM) and 0.05% w/v collagenase with recirculation for 
10 min, and 100 ml of the same buffer containing 0.1% w/v 
collagenase with recirculation for 20 min, was pumped through the 
liver. After this perfusion, the loosened liver tissue was 
carefully teared apart and diluted with HEPES-TES buffer 
containing 2% albumine, and the obtained crude cell suspension 
was filtered through 250 urn nylon mesh and the filtrate 
centrifuged. The cell pellet was resuspended in HEPES-TES buffer 
containing 2% w/v albumin. After incubation of this liver cell 
suspension in a shaking waterbath (120 rpm) at 37 oC for 20 
minutes, filtration, gentle centrifugation and cell washing, the 
final pellet was resuspended in a HEPES-TES buffer solution 
(pH 7.6) containing 2% albumin. The viability (as judged by 
trypan-blue exclusion) ranged from 83-93%. 
Human hepatocytes 
Human hepatocytes were isolated from postmortal 
tissues, obtained from kidney transplant donors, 
described (Neis, 1985a,с) 
Mutagenicity assay 
The Salmonella/hepatocyte suspension assay was carried out as 
follows. In a shaking waterbath (210 rpm), closed sterile 
scintillation vials (20 ml) each containing 387.5 ul of 




exponential-growing suspension of Salmonella typhimurium (about 
g 
2 χ 10 bacteria/ml) and 12.5 ul of a solution of the compound 
under test, were incubated in triplicate at 37 oC for 2 h. DMN 
and DEN were dissolved in saline and sterilized by filtration. 
The other test compounds were dissolved in dimethylsulfoxide 
(DMSO). After incubation, each mixture was plated with a molten 
top agar containing biotin (no histidine). The number of 
revertant colonies was counted after 48 h of incubation at 37 oC. 
Measurement of the metabolism of B(a)P by monkey and human liver 
S9 preparations 
The metabolism of B(a)P by monkey and human liver S9mix (9000 xg 
liver supernatant supplemented with a NADPH regenerating system) 
was measured by use of high pressure liquid chromatographic 
(HPLC) determination of ether-soluble metabolites of B(a)P as 
previously described (Jongeneelen, 1985; Neis, 1985c). B(a)P 
(25 uM) was incubated with the S9mix for a period of 2 h and 
subsequently metabolites were extracted with ether. 
Identification of metabolites was done by comparison of retention 
times with reference В(a)P-metabolites. The monkey liver S9mix 
was prepared in the same manner as the human liver S9mix, as 
previously described (Neis, 1985c). 
RESULTS 
Mutagenicity of BZ, MABZ and DABZ 
Table I shows the mutagenic activity of BZ, MABZ and DABZ towards 
Salmonella typhimurium strain TA1538 after metabolic activation 
with isolated hepatocytes of monkey I, II and III. The 
hepatocytes of these animals appeared to be capable of activating 
all three compounds to mutagenic products. With all three 
hepatocyte preparations, MABZ appeared to be the most mutagenic, 
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whereas BZ was slightly more active than DABZ. Among these 
monkeys slight inter indi vidual differences in activating capacity 
of the isolated hepatocytes were seen. 
With human hepatocytes a much higher mutagenicity of these 
compounds was found. It is striking that with the human 
hepatocytes, unlike the monkey hepatocytes, DABZ apeared far more 
mutagenic than the parent compound BZ. 
TABLE I 
MUTAGENIC EFFECTS ON SALMONELLA TYPHIMURIUM TAI 538 OF BZ, MABZ AND DABZ, 
ACTIVATED BY ISOLATED HEPATOCYTES OF MONKEY (,Μαοααα fascicularis) AND MAN 











































628 ± 313 
1738 ± 1091 







Control revertant number was 8 ± 1. 
* For monkey, values are the mean revertant number of triplicate incubations. 
** For human, values for BZ are the mean ± S.E.M. of experiments with hepatocyte 
preparations of five different human subjects. Values for MABZ and DABZ are 
obtained with hepatocytes of one human subject. 
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TABLE II 
MUTAGENIC EFFECTS ON SALMONELLA TYPHIMURIUH OF 2-AF, 2-AAF, B(a)P, 7,12-DMBA, QMN AND DEN, ACTIVATED BY ISOLATED 
HEPATOCYTES OF MONKEY Шасаса fasaioularis) AND MAN 
Tester Strain TAI 538 
Compound 2-AF 2-AAF 
Species Μ Η Μ Η 
TAI 00 
B(a)P 7,12-DMBA 
Μ Η Μ Η 
hlsG46 
DMN DEN 





























56 44t 6 
99 2191180* 
318 1751105* 
623 2541 61 
control 2 21 1 2 21 1 
50 (UM) 8 641 31 9 nt 
250 (uM) 10 1891 78 13 841 36 
1000 (uM) 12 13691997 17 901 35 
For monkey (M), values are mean revertant number of triplicate incubations with isolated hepatocytes of monkey IV. 
For human (H), values are mean revertant number 1 S.E.M. of experiments with hepatocyte preparations of four different 
human subjects, except * are the mean 1 S.E.M. of hepatocyte preparations of two human subjects. 
nt = not tested. 
Mutagenicity of 2-AF, 2-AAF, B(a)P, 7,12-ΡΜΒΑ, DMN and DEN 
Table II shows the mutagenicity of genotoxic compounds of 
different chemical classes towards Salmonella typhimurium after 
activation by isolated hepatocytes of monkey IV and man. The 
dose-responses presented in Table II show that all the tested 
compounds were activated to mutagens, by isolated hepatocytes of 
monkey IV. 
The arylamines 2-AF and 2-AAF and the nitrosamines DMN and DEN 
were poorly activated by the monkey hepatocytes, in comparison to 
the values obtained with human hepatocytes. In contrast, the 
reverse was found for the polycyclic arylhydrocarbons В (a)Ρ and 
7,12-DMBA. These compounds appeared highly mutagenic towards 
Salmonella typhimurium ТАІОО when activated with the monkey 
hepatocytes. 
Metabolism of B(a)P 
In a previous study (Neis, 1985c) we observed a relatively weak 
mutagenic activity of B(a)P towards Salmonella typhimurium ТАІОО, 
after metabolic activation with isolated hepatocytes of four 
human subjects. In that investigation a weak metabolic 
activation capacity of the human hepatocytes towards B(a)P, as 
measured by a relatively low formation of ether-soluble B(a)P 
metabolites, e.g. 3-OH B(a)P, after incubation of human S9mix 
with B(a)P was suggested as the reason for the observed low 
mutagenicity of B(a)P. 
Therefore, the capability of monkey S9mix to metabolize B(a)P was 
measured using HPLC determination of ether-soluble metabolites. 
Figure 1 shows the metabolite profile obtained with the S9mix of 
monkey IV and a representative human liver S9mix. 
In the presence of the monkey liver S9mix the conversion of B(a)P 
to 9-0H-B(a)P and 3-0H-B(a)P proceeded more effective than with 
the human liver preparation. In agreement to this a lower amount 
of unmetabolized B(a)P was found after incubation with the monkey 
S9mix compared with the human S9mix (Figure 1). 
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U n i t s of ( luoiescence 
¿О 60 
Time (mm) 
Fig. 2. Comparison of the metabolism of В(a)Ρ by monkey and human l i v e r 
ЗЭтіх, using high pressure l iqu id chromatographic determinat ion of e t h e r -
soluble m e t a b o l i t e s . Note q u a n t i t a t i v e d i f ferences between monkey and man. 
DISCUSSION 
The i s o l a t e d monkey h e p a t o c y t e s appeared t o be c a p a b l e of 
a c t i v a t i n g a l l of t h e t e s t e d compounds t o p r o d u c t s mutagenic 
towards Sa lmonel la typhimurium. However, g r e a t d i f f e r e n c e s in 
t h e mutagenic p o t e n c y between chemical c l a s s e s were o b s e r v e d . 
BZ, MABZ and DABZ were found t o be p o o r l y a c t i v a t e d by monkey 
h e p a t o c y t e s . MABZ appeared the most mutagenic (Table I ) . With 
human h e p a t o c y t e s BZ, MABZ and DABZ were h i g h l y mutagenic towards 
Sa lmonel la typhimurium TA1538, showing MABZ and DABZ e q u a l l y 
a c t i v e but far more mutagenic than t h e p a r e n t compound BZ 
(Table I ) . 2-AF and 2-AAF were a l s o only weakly mutagenic 
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towards TA1538 in the presence of monkey hepatocytes (Table II). 
In contrast, with isolated hepatocytes of four human subjects, 
2-AF and 2-AAF appeared to be relatively highly mutagenic. The 
reason for these interspecies differences may be attributed to a 
lower rate of N-hydroxylation (an essential step in the 
activation of arylamines and arylamides) in the monkey 
hepatocytes compared with human hepatocytes. 
The nitrosamines DMN and DEN were also found only weakly 
mutagenic in the presence of monkey hepatocytes, whereas these 
compounds were highly mutagenic when activated by isolated human 
hepatocytes. In contrast, the polycyclic arylhydrocarbons B(a)P 
and 7,12-DMBA were found highly mutagenic after metabolic 
activation with monkey hepatocytes, unlike human hepatocytes. 
Presumably, the higher mutagenicity of B(a)P with monkey than 
with human hepatocytes is due to a higher activating capacity of 
the monkey hepatocytes. The monkey S9 liver preparation appeared 
to be more active in metabolizing B(a)P to ether-soluble 
metabolites, than human liver S9mix (Figure 1). Much higher 
amounts of 3-0H-B(a)P, a metabolite reported as marker for 
mono-oxygenase activity an essential step in the metabolic 
activation of B(a)P to genotoxic products, were found after 
incubation of B(a)P with monkey liver S9mix (Figure 1). Monkey 
liver has been reported to possess a relatively low 
GSH-transferase activity (Chasseaud, 1977). Therefore, a low 
detoxification rate may also contribute to the high mutagenicity 
of B(a)P in the presence of monkey hepatocytes. After incubation 
of B(a)P with the monkey S9 liver preparation 7,8-diol-B(a)P, 
9,10-diol-B(a)P, 9-0H-B(a)P and 3-0H-B(a)P were detected 
(Figure 1). Hundley and Freudenthal (1977) have reported these 
compounds as metabolites of B(a)P after incubation with liver 
microsomes of rhesus monkey (Macaca mulatta); 3-0H-B(a)P was 
reported to be the major metabolite. These authors reported only 
slight inter individual differences between the monkeys in the 
formation of these metabolites. 
The obvious divergent mutagenicity data obtained with isolated 
monkey hepatocytes as compared with human hepatocytes are 
somewhat surprising, since one should expect that a subhuman 
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primate species like the Macaca fascicularis would resemble the 
human species more closely than other laboratory animals. 
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SUMMARY 
The mutagenic potency of isoniazid (a widely used ant i tubercular 
drug) towards Salmonella typhimurium strain hisG46 was studied in 
the Salmonella/hepatocyte suspension assay, comprising isolated 
human or rat hepatocytes as metabolic system. The potency of 
isoniazid to induce DNA-excision repair in these hepatocytes was 
also measured. 
With rat hepatocytes isoniazid appeared to be only weakly 
mutagenic and did not induce significant increases in 
hepatocellular DNA-excision repair. With isolated hepatocytes of 
two human subjects isoniazid appeared also only weakly mutagenic. 
However, with hepatocytes of two other human subjects isoniazid 
was found higly mutagenic. Comparable results were obtained for 
the induction of hepatocellular DNA-excision repair. 
INTRODUCTION 
Isoniazid (isonicotine acid hydrazide; INH) has been widespread 
used for many years for the therapeutic and prophylactic 
treatment of tuberculosis. Many studies have indicated that 
prolonged therapy with this drug may lead to severe liver injury 
in humans. In mice INH has been reported to induce lung tumors 
(IARC Monograph, 1974). Its carcinogenic activity in rats is 
however inconclusive or negative (Jansen, 1980). 
In many species the major route of metabolism of INH involves 
acetylation to acetyllNH. Large differences between individuals 
in the acetylation of INH are reported (Ellard, 1975; Evans, 
1964; Mitchell 1975a; Nelson, 1976; Weber, 1983). This variation 
is due to the genetic difference in cytosolic N-acetyltransferase 
activity, primarily located in the liver. Metabolic studies have 
shown, that people having a rapid acetylation phenotype are 
exposed to much more acetyllNH and acetylhydrazine than people 
having a slow acetylation phenotype (Ellard, 1975; Mitchell, 
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1975a). An increasing number of evidence exist, that INH related 
liver injury is caused by the metabolite acetylhydrazine, formed 
by metabolic hydrolysis of acetyllNH. (Gatehouse, 1984; 
Mitchell, 1975a; Nelson, 1976; Timbrell, 1980; Tornasi, 1983). 
The acetylhydrazine formed, has been reported to be metabolized 
by the cytochrome-P450 enzym system to reactive acylating species 
capable of reacting covalently with tissue macromolecules 
(Nelson, 1976; Timbrell, 1980; Tornasi, 1983). 
We recently suggested that isolated human hepatocytes may be a 
very good model for the study of the potential genotoxicity of 
compounds to humans (Neis, 1985a and 1985c). In the present 
investigation the ability of INH to evoke hepatocellular 
DNA-excision repair and bacterial mutagenicity was studied using 
isolated hepatocytes from rats and from four human subjects. The 
N-acetylating activity of these cells was studied in relation to 
their capacity to bioactivate INH. 
MATERIALS AND METHODS 
Chemicals 
Chemicals were obtained from the following sources: Isoniazid 
(isonicotinic acid hydrazine; INH) was from OPG (Utrecht, The 
Netherlands); collagenase (from Clostridium histolyticum) was 
from Boehringer (Mannheim, FRG); Eagle's minimal essential medium 
including Hank's salts, and foetal calf serum were from Biomed; 
(3H)-Thymidine (3H-TdR), spec. act. 26 Ci/mmol was from The 
Radiochemical Centre (Amersham, UK). 
All other chemicals used were of high purity. 
Preparation of isolated rat and human hepatocytes 
Isolated rat hepatocytes were prepared by a two-step collagenase 
perfusion technique as previously described (Neis, 1984 and 
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1985b). The human hepatocytes were prepared from liver samples 
(200-400 g) obtained from kidney transplant-donors killed in a 
traffic accident. The human hepatocytes were isolated by a 
modified two-step collagenase perfusion-technique as previously 
described (Neis, 1985a and 1985c). All manipulations were 
carried out under sterile conditions. 
The rat and human 9000 xg liver supernatant fractions (S9mix) 
were prepared as described previously (Neis, 1985c). 
Mutagenicity assay 
The Salmonella/hepatocyte suspension assay was carried out as 
follows. In a shaking waterbath (210 rpm), closed sterile 
scintillation vials, (20 ml) each containing 387.5 ul of 
hepatocyte suspension (10 χ 10 viable cells/ml), 0,1 ml of an 
exponential-growing suspension of Salmonella typhimurium strain 
9 
hisG46 (about 2.5 χ 10 bact./ml) and 12.5 ul of a sterile 
solution of INH in saline, were incubated in triplicate at 37 oC 
for 2 h. After incubation, each mixture was plated with a molten 
top agar containing biotin (no histidine). The number of 
revertant colonies was counted after 48 h of incubation at 37 oC. 
The Salmonella/S9mix suspension assay was performed as described 
for the hepatocyte assay except that liver S9mix was used instead 
of isolated hepatocytes. The Salmonella/S9mix plate assay 
(Ames-assay) was performed as previously described (Neis, 1985c). 
DNA-repair assay 
Hepatocellular DNA-excision repair was measured as 3H-TdR 
incorporation into DNA by a rapid and simple technique via liquid 
scintillation counting as described by Brouns et al (1979), with 
slight modifications. The isolated hepatocytes were resuspended 
in Eagle's minimal essential medium, supplemented with Hank's 
salts, 10% foetal calf serum, streptomycin 0.01% and penicillin-G 
100 U/ml. In a shaking waterbath (120 rpm), closed scintillation 
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vials (20 ml) each containing 487.5 ul of hepatocyte suspension 
(1 x 10 viable cells/ml) and 12.5 ul of a solution of INH in 
saline, were incubated in triplicate at 37 oC for 1 h. To three 
vials, serving as control, 12.5 ul saline was added. 
Subsequently, 3H-TdR was added to each vial to a final 
concentration of 1 uCi/ml, whereafter incubation was continued 
for 2 h. Next, 2 ml of saline was added to each vial. Each 
mixture was transferred to centrifuge tubes and centrifuged at 
3000 xg for 10 min and the supernatants were carefully decanted. 
To the cell pellets, 1 ml 6M NaSCN solution was added under 
vigorous shaking, and were left to stand overnight at room 
temperature to achieve complete lysis of the cells. 
Subsequently, after addition of 1 ml carrier DNA solution 
(0.1 mg DNA/ml), macromolecules were precipitated by addition of 
2 ml 20% ice-cold TCA solution under vigorous shaking. After 
standing at -20 oC for 30 min the tubes were centrifuged at 30 xg 
for 15 min. The pellets were washed once with 70% ethanol and 
once with cold 0.5N PCA, after which the precipitated DNA was 
selectively solubilized with 0.5 ml 0.5N PCA at 80 oC for 60 min. 
The tubes were then centrifuged at 3000 xg for 15 min, and the 
supernatants transferred to scintillation vials. After addition 
of 5 ml Aqua Luma to each vial, the 3H-radioactivity was measured 
by a Philips liquid-scintillation analyzer (efficiency 39-42%). 
2-Aminofluorene a well known precarcinogen was used as a positive 
control, to ensure that the isolated hepatocytes possessed an 
adequate metabolic activation and/or DNA-repair activity. 
Cytochrome-P450 content 
The cytochrome-P450 content of hepatocytes was measured with the 
cytochrome-P450 CO-difference spectra after reduction with 
sodiumdithionite, according to the method of Omura and Sato 
(1964). Prior to the measurement of the cytochrome-P450 content 
of the isolated hepatocytes, the hepatocyte suspension was 
sonicated twice for 20 sec with an interval of 30 sec in an MSE 
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Ultrasonic Disintegrator (100 W) at maximal energy. During this 
step the suspension was cooled on ice. 
N-acetylation assay 
The N-acetylation activity of the isolated hepatocytes was 
measured with benzidine as a model substrate (Glowinsky et al. 
(1978) have shown that benzidine, a carcinogenic arylamine, was 
N-acetylated polymorphically by human liver in vitro in a similar 
fashion as INH). 
The following procedure was used. In a shaking waterbath 
(210 rpm), closed vials, containing 487.5 ul hepatocyte 
suspension (10 χ 10 viable cells/ml) and 12.5 ul of a solution 
of benzidine in DMSO (final concentration 100 uM) were incubated 
in triplicate at 37 oC during different time intervals. Next, 
the mixtures were pipetted into cold TCA and after centri fugation 
the amount of diazotable amine was determined according to the 
method of Bratton and Marschall (1939). The extent of 
acetylation was taken as the difference between initial and 
remaining free amine and expressed as pmol of substrate 
acetylated per min per 10 cells. No non-enzymatic disappearance 
of the substrate was observed. 
RESULTS 
Mutagenicity 
The mutagenicity of INH towards Salmonella typhimurium strain 
hisG46 after activation with isolated rat and human hepatocytes 
is presented in Figure 1. INH appeared to be only weakly 
mutagenic when activated with rat hepatocytes. 
With human hepatocytes great inter individual differences were 
observed in the activating potential towards INH. 
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INH concentration (mM) 
Fig . 1. Mutagenicity of INH towards Salmonella typhimunum s t r a i n hisG46 
a f t e r metabolic a c t i v a t i o n with i s o l a t e d human or r a t hepatocytes . For human 
hepatocytes values are the means of determinat ions in t r i p l i c a t e . For r a t 
hepatocytes values are the means (±SEM) of s ix separate experiments with 
hepatocyte p r e p a r a t i o n s of d i f f e r e n t r a t s . 
The hepatocytes of subject 3 and 6 act ivated INH only weakly to 
mutagenic products . The mutagenic values were comparable to 
those observed with r a t hepatocytes. However, a high mutagenic 
a c t i v i t y of INH was observed with the hepatocytes of subject 5 
and, in p a r t i c u l a r , of subject 4 (Figure 1) . Even at r e l a t i v e 
low concentrat ions (200 uM) a high mutagenicity ( 50 times 
background rever tant number) was observed af ter a c t i v a t i o n with 
hepatocytes of subject 4. 
The d i r e c t mutagenicity of INH and the mutagenicty of INH af ter 
metabolic a c t i v a t i o n with 9000 xg l i v e r supernatant (S9mix) of 
r a t s or the four human subjects , was also measured. INH was 
incubated with Salmonella typhimurium hisG46 in the suspension 
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assay (up to a concentration of 5mM), or in the plate assay (up 
to 12.5 umoles/plate), with and without rat or human liver S9mix. 
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Fig. 2. Incorporation of 3H-TdR into hepatocellular DNA as a result of 
exposure of isolated human or rat hepatocytes to different concentrations of 
INH. For human hepatocytes values are the means (±SEM) of triplicate deter-
minations. For rat hepatocytes values are the means (±SEM) of three separate 
experiments with hepatocyte preparations of different rats. 
DNA-repair 
DNA-repair was determined with rat hepatocytes and with the 
hepatocytes of subject 5 and 6. The induction of unscheduled 
DNA-repair (measured as the incorporation of 3H-TdR into 
hepatocellular DNA), as a result of exposure of the isolated rat 
and human hepatocytes to different concentrations of INH are 
shown in Figure 2. 
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At the concentrations of INH tested no significant increase in 
DNA-repair could be detected with rat hepatocytes. The 
hepatocytes of the two different subjects responded differently 
to the exposure to INH. No increase in DNA-repair was seen in 
the hepatocytes of subject 6. Whereas, in the hepatocytes of 
subject 5 a relatively high increase in DNA-repair was observed. 
Cytochrome-P450 content 
The cytochrome-P450 content of the isolated hepatocytes of six 
rats and the four human subjects is shown in Table I. Great 
differences in the cytochrome-P450 content between the four 
subjects were seen. The hepatocytes of subject 4 possessed a 
high cytochrome-P450 content relative to the other three 
subjects. As was judged from the clinical data this could not be 
due to induction by drugs given while on live support system. It 
may be due to induction by prior drug treatment, but this could 
not be checked. 
TABLE I 
CYTOCHROME-P450 CONTENT AND N-ACETYLATION IN ISOLATED HUMAN AND RAT HEPATOCYTES 
Subject Age Sex Viability* Cytochrome-P450 content N-acetylation** 





95 270 ± 30*** 77 ± 8*** 
* Percent of isolated cells excluding trypan-blue (0.12 % w/v). 
** Initial N-acetylation rate of 100 uM benzidine (modelsubstrate). 



















The N-acetylation capacity of the isolated hepatocytes from two 
persons and six rats was determined with benzidine as a substrate 
(Table I). A great difference was found in the N-acetylating 
capacity of the hepatocytes of subject 5 compared with subject 6. 
The hepatocytes of subject 5 possessed an N-acetylation rate five 
times faster than the hepatocytes from subject 6. The rat 
hepatocytes appeared to have an N-acetylation rate approximately 
equal to that of subject 5. 
DISCUSSION 
Testing of INH in combination with rat hepatocytes revealed that 
this compound is weakly mutagenic and does not induce a 
significant increase in DNA-excision repair (Figures 1 and 2). 
With hepatocytes from human origin (subject 4 and 5), high 
genotoxic activity was found after exposure to INH, whereas with 
the cells from subjects 1 and 4 values were obtained that are 
comparable with those of the rats (Figures 1 and 2). Such 
variations are well compatible with previous reported differences 
in hepato-toxicity of INH between rat and man. Thomas et al. 
(1977) showed by measurement of serum transaminase levels in rats 
dosed with INH, that the rat is not susceptible to an acute 
hepatotoxic reaction to INH. Mitchell et al. (1975b) also 
reported that hepatic necrosis could not be produced in the rat 
even after lethal INH doses. Probst et al. (1983) reported INH 
to be also negative in a genetic toxicology animal based 
test-battery, comprising bacterial-mutation, DNA-repair, 
L5178Y-mutation and in vivo SCE. 
Thomas et al. (1977) found quantitative differences in the 
metabolism of INH between rats and humans. Their results 
indicated that the rat is unable to hydrolyse acetyllNH to 
acetylhydrazine as rapidly as humans, thereby explaining the 
lower toxicity in rat compared to man. All these findings 
124 
indicate that the rat may not be a proper model to study the 
(geno)toxicity of 1NH to humans. 
Several investigations have indicated the importance of the 
N-acetylation reaction in the bioactivation of INH (Gatehouse, 
1984; Nelson, 1976; Timbrell, 1980; Tornasi, 1983). We found that 
the N-acetylation activity of isolated hepatocytes from two human 
subjects were widely divergent (Table I). The N-acetylation 
activity of the hepatocytes of subject 5 was almost five times 
higher than that of subject 6. A good correlation has been 
reported between the capacity to acetylate INH in vivo and the in 
vitro activity of the liver acetylating enzymes (Evans, 1964). 
In man in vivo as well as in vitro with liver-biopsies, a 
three-five times faster acetylation of INH, acetylhydrazine and 
sulfadimide has been reported for rapid acetylators than for slow 
acetylators (Ellard, 1975). Rat hepatocyte preparations appeared 
to possess an acetylation activity almost equal to that of the 
hepatocytes of subject 5. This is well compatible with the 
results of Thomas et al. (1977) and Ellard et al. (1975) that 
indicated that INH is acetylated to acetyllNH at the same rate in 
rats as in rapid acetylating humans. 
The relation between acetylation polymorphism in man and the 
toxicity of INH to the liver has been studied at epidemiological, 
clinical and basic levels. However, considerable controversy has 
generated from these studies (Weber, 1983). Examination of INH 
metabolites in humans by Mitchell et al. (1975a) revealed that 
rapid acetylators are exposed to 46% more acetylhydrazine 
(proximate genotoxic metabolite) than slow acetylators. Our 
observation, that with the rapidly acetylating hepatocytes of 
subject 5 a much higher genotoxicity was found, makes it 
attractive to assume that rapid-acetylator humans may be at 
increased risk for INH liver injury. However, because the 
activation of INH, apart from N-acetylation, also involves 
cytochrome-P450 mediated metabolism, the observed difference in 
INH genotoxicity may also be partly due to inter individual 
variations in the cytochrome-P450 system. 
Although liver necrosis presumably due to a reactive metabolite 
is found in therapy with INH (Lenders, 1983), it is not known 
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whether or not it is also a carcinogen to humans. However, the 
present observations on mutagenicity and induced DNA-repair by 
INH with human hepatocytes might be a reason for concern about a 
possible risk of neoplasm after INH therapy. 
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SUMMARY 
The effects of ethanol feeding to rats, over a 6 week period, on 
the activation of genotoxic compounds of different chemical 
classes, requiring metabolic conversion to exert their mutagenic 
activity, were studied in isolated rat hepatocytes. The 
influence of such treatment on cytochrome-P450 content and 
N-acetylation in isolated hepatocytes was also investigated. 
Benzidine (BZ), dimethylnitrosamine (DMN), diethylnitrosamine 
(DEN), isoniazid (INH) and cyclophosphamide (CP) were more 
effectively activated to products mutagenic towards Salmonella 
typhimurium by hepatocytes from ethanol pretreated rats than by 
hepatocytes from controls. The mutagenic potency of 
2-aminofluorene (2-AF) and 2-acetylaminofluorene (2-AAF) was not 
influenced by ethanol pretreatment. Ethanol consumption was 
found to be associated with increased cytochrome-P450 content and 
enhanced N-acetylation in the isolated hepatocytes. 
Our results support the hypothesis that an alteration of the 
hepatic drug-metabolizing system may be responsible for the 
ethanol induced increase in susceptibility to certain genotoxic 
compounds. 
INTRODUCTION 
Ethanol can induce a variety of metabolic and morphologic changes 
in both animal and human liver (De Carli, 1967; Elves, 1984; 
Ishii, 1973; Khanna, 1976; Rubin, 1968; Schnellmann, 1984). 
Chronic ethanol intake, for instance, alters the hepatic 
drug-metabolizing system so that certain drugs and endogenous 
compounds are metabolized more rapidly. Ethanol pretreatment may 
change the balance between toxication and detoxication, a crucial 
factor in determining the genotoxic potency of a compound. As a 
consequence, the potency of agents that become genotoxic as a 
result of metabolic activation may be altered. Recent findings 
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indicate that ethanol consumption in rodents results in an 
increased microsomal capacity to activate a number of 
pregenotoxic agents (Garro, 1981; Capel, 1979; Smith, 1984). 
Isolated hepatocytes have been shown to be a valuable tool for 
the study of the biotransformation of pregenotoxic agents, 
particularly those compounds that undergo complex reaction 
sequences. Metabolism in isolated hepatocytes more closely 
resembles the biotransformation in the liver in vivo than does 
metabolism in subcellular liver fractions (Bos, 1982; Glatt, 
1981; Billings, 1977). The natural balance between activation 
and deactivation reactions is better preserved in intact 
hepatocytes than subcellular fractions, e.g. microsomes. 
In the present investigation, isolated rat hepatocytes were used 
to study the influence of ethanol feeding to rats on the 
mutagenic activation of genotoxic compounds of different chemical 
classes, all requiring metabolic conversion to exert their 
genotoxicity. The influence of ethanol pretreatment on 
N-acetylation was particularly investigated, because of its 
importance in the mutagenic activation of some of the compounds 
studied. 
MATERIALS AND METHODS 
Chemicals 
Chemicals were obtained from the following sources: Ethanol used 
for the treatment of rats was from Nedalco (Bergen op Zoom, The 
Netherlands); BZ from Merck (Darmstadt, FRG); 2-AF and 2-AAF and 
DMN from Aldrich Europe (Beerse, Belgium); DEN from Aldrich 
Chemical Co. Inc. (Milwaukee, USA); CP from Asta (Brackwede, 
FRG); INH from OPG (Utrecht, The Netherlands). D-biotin, 
L-histidine-HCl, collagenase type I were obtained from Sigma (St. 
Louis, Missouri, USA). Purified agar was from Difco 
Laboratories, nutrient broth No. 2 from Oxoid Ltd. (Basingstoke, 
Great Britain). All other chemicals used were of high purity. 
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Ethanol pretreatment 
Male Wistar rats were fed a standard laboratory diet. The four 
ethanol treated rats received a 15% (v/v) ethanol solution in 
place of drinking water for 6 weeks, whereas the four control 
rats received drinking water. Ethanol treated rats were switched 
to drinking water 16 h prior to isolation of hepatocytes. Prior 
to the isolation of hepatocytes, all rats were deprived of food 
overnight. At the time of use no difference in body weight 
between the control and the ethanol fed rats was observed. 
Preparation of isolated hepatocytes 
Hepatocytes were isolated according to a previously described 
procedure (Neis, 1984). All manipulations were performed under 
sterile conditions. The final cell suspension was diluted to a 
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density of 10 χ 10 viable cells/ml. Trypan-blue exclusion 
showed the presence of about 95% viable cells for control as well 
as ethanol pretreated rats. 
Mutagenicity assay 
The Salmonella/hepatocyte mutagenicity assay was carried out as 
follows. In a shaking waterbath (210 rpm) closed sterile 
scintillation vials (20 ml), each containing 387.5 ul of 
hepatocyte suspension (10 χ 10 viable cells/ml), 0.1 ml of an 
exponential-growing suspension of Salmonella typhimurium (about 
g 
2.0 χ 10 bacteria/ml) and 12.5 ul of a solution of the compound 
under test, were incubated in triplicate at 37 oC for 2 h. BZ, 
2-AF and 2-AAF were dissolved in dimethylsulfoxide, whereas DMN, 
DEN, INH and CP were dissolved in saline and sterilized by 
filtration. After incubation, each mixture was plated with a 
molten top agar containing biotin (no histidine). The number of 
revertant colonies was counted after 48 h of incubation at 37 oC. 
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N-acetylation assay 
The rate of N-acetylation in the hepatocyte suspension was 
measured with p-aminobenzoic acid (PABA) or benzidine (BZ). The 
procedure was as follows. In a shaking waterbath (210 rpm) 
closed sterile scintillation vials (20 ml), each containing 487.5 
ul of hepatocyte suspension (8 χ 10 viable cells/ml) and 12.5 ul 
of a solution of PABA or BZ (4 mM) in dimethylsulfoxide were 
incubated in triplicate at 37 oC for different time intervals. 
Next, the concentration of PABA or BZ in these mixtures was 
measured according to the method of Bratton and Marshall (1939). 
The disappearance of the substrate remained linear with time up 
to 45 min incubation. 
Cytochrome-P450 content 
The cytochrome-P450 content of hepatocytes was measured with the 
cytochrome-P450 CO-difference spectra after reduction with sodium 
dithionite, according to the method of Omura and Sato (1964). 
Prior to the measurement of the cytochrome-P450 content of the 
isolated hepatocytes, the hepatocyte suspension was sonicated 
twice for 20 sec with an interval of 30 sec in an MSE Ultrasonic 
Disintegrator (100W) at maximal energy. During this step the 
suspension was cooled on ice. 
RESULTS 
The influence of ethanol on cytochrome-P450 content and 
N-acetylation in isolated hepatocytes 
Table I shows the N-acetylation rate in isolated hepatocytes of 
four control and four ethanol pretreated rats. The N-acetylation 
rate of PABA and BZ appeared significantly (Wilcoxon test, 
P<0.05) increased after ethanol pretreatment, by about 45%. The 
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cytochrome-P450 content of isolated hepatocytes of four control 
and four ethanol pretreated rats was also compared. The ethanol 
pretreatment appeared to result in a significant (Wilcoxon test, 
P<0.05) increase in the cytochrome-P450 content of the isolated 
hepatocytes. The cytochrome-P450 content was increased from 
e fi 
0.26±0.02 (mean SEM) nmoles/10 cells to 0.36+0.02 nmoles/10 
cells. 
TABLE I 








































Values r e p r e s e n t the N-acety lat ion r a t e in pmol/min per 10 c e l l s . 
Experiment number r e f e r s t o four separate experiments with hepatocyte 
p r e p a r a t i o n s from d i f f e r e n t r a t s . For both s u b s t r a t e s d i f ferences in 
N-acetylat ion are s i g n i f i c a n t (P<0.05, Wilcoxon t e s t ) . 
M u t a g e n i c i t y 
The m u t a g e n i c i t y of 2-AF, 2-AAF, BZ, DMN, DEN, INH and CP towards 
Sa lmonel la typhimurium a f t e r m e t a b o l i c a c t i v a t i o n with i s o l a t e d 
h e p a t o c y t e s of c o n t r o l and e t h a n o l p r e t r e a t e d r a t s i s shown in 
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Fig. 1. Mutagenicity of 2-AF, 2-AAF and BZ towards Salmonella typhimurium 
strain TA1538; of DMN, DEN and INH towards strain hisG46; and of CP towards 
strain TAI535, after metabolic activation with isolated hepatocytes of 
control (·——·) and ethanol pretreated rats (O—O). Values represent the mean 
(±SEM) of four separate experiments with hepatocyte preparations from 
different rats, each assayed in triplicate. 
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Ethanol pretreatment resulted in an increase in the mutagenicity 
of the arylamine BZ, whereas the mutagenicity of 2-AF and 2-AAF 
was not influenced (Figure la). 
An increase in mutagenicity was also observed (Figure lb) for the 
dialkylnitrosamines DMN and DEN. 
Cytostatic CP was also more effectively transformed to products 
mutagenic to Salmonella typhimurium by hepatocytes of ethanol 
pretreated rats than by hepatocytes from control rats 
(Figure 1c). Pretreatment also increased the mutagenicity of INH 
(Figure 1c). 
DISCUSSION 
The ability of ethanol to potentiate the toxicity of several 
drugs is well documented (Embly, 1977; Maling, 1975; Moldeus, 
1980; Strubelt, 1978 and 1980). As the most attractive 
hypothesis to explain this potentiation, these authors suggested 
that ethanol, by altering the drug-metabolizing system, causes 
more efficient conversion of the pretoxic agents into highly 
reactive intermediates. 
In our study, ethanol pretreatment resulted in an increase in the 
cytochrome-P450 content of the isolated hepatocytes. An increase 
in the hepatic cytochrome-P450 content and enhanced 
cytochrome-P450 dependent metabolism of several drugs after 
ethanol treatment is a generally recognized phenomenon. Ethanol 
pretreatment may increase the content of certain cytochrome-P450 
isoenzymes, thereby changing the balance between 
cytochrome-P450-dependent toxication and detoxication reactions. 
This may result in potentiation of toxicity for several 
compounds, whereas for others the toxicity may be unchanged or 
even reduced (Strubelt, 1978). Because participation of 
cytochrome-P450 is important in the activation of the tested 
pregenotoxic compounds, one would expect a change in the 
mutagenic potential of the tested compounds after metabolic 
activation with hepatocytes from ethanol pretreated rats compared 
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with hepatocytes from controls. Ethanol pretreatment resulted in 
an increased mutagenicity of BZ, INH, CP, DMN and DEN. However, 
the mutagenicity of 2-AF and 2-AAF was not influenced (Figure 1). 
Ethanol pretreatment significantly enhanced (by 45%) the 
N-acetylation capacity of the isolated hepatocytes (Table I). 
Olsen (1978 and 1982) reported an ethanol induced increase in the 
rate of sulfadimidine and procainamide acetylation in man. They 
also found an ethanol induced increase of about 30% in the rate 
of sulfadimidine acetylation in suspensions of isolated rat 
hepatocytes (Olsen, 1978). Whether our observed increase in 
N-acetylation is the result of an increase in the amount of 
N-acetyltransferase, or due to an increase in acetyl-CoA, the 
cofactor for the N-acetylation reaction, as suggested by Olsen 
(1978), is yet unclear. 
The conversion of BZ, 2-AF and 2-AAF to metabolites capable of 
interaction with cellular macromolecules is important with 
respect to their genotoxic properties. The metabolic activation 
of arylamines is a complex process, which is believed to proceed 
via N-hydroxylation and ester ification. These compounds can also 
undergo N-acetylation in a number of species, including man. The 
balance between acetylation and deacetylation plays an essential 
role in determining susceptibility to arylamine genotoxicity 
(Neis, 1984 and 1985). Therefore, one might expect that the 
observed increase in N-acetylation will influence the activation 
of BZ, 2-AF and 2-AAF into mutagenic products. For 
monofunctional arylamines like 2-AF, 4-aminobiphenyl and 
2-aminoanthracene the N-acetylation reaction seems to reduce the 
mutagenic potency (Connor, 1983; Neis, 1984). Conner et al. 
(1983) showed that the mutagenic potency of 2-AAF was 
significantly lower than the corresponding 2-AF. In contrast, 
for the bifunctional arylamine BZ, the N-acetylation is an 
essential step in the metabolic activation of this compound into 
genotoxic species (Martin, 1982; Neis, 1984). 
Therefore, we suggest that the increase in N-acetylation will 
enhance the mutagenicity of BZ but will decrease the mutagenicity 
of 2-AF and 2-AAF. The observed increase in BZ mutagenicity 
(Figure la) is compatible with the increased N-acetylation rate 
137 
and cytochrome-P450 content. The unchanged mutagenicity of 2-AF 
and 2-AAF (Figure la) may be explained by the fact that opposite 
effects on mutagenicity, due to an increase in N-acetylation 
(deactivation) and cytochrome-P450 dependent deactivation 
reactions on the one hand and an increase in cytochrome-P450 
dependent activation on the other, compensate for each other. 
DMN has also been used as a model compound in other studies 
concerning the influence of ethanol on the bioactivation of 
pregenotoxic agents. In vitro studies with subcellular liver 
fractions showed that DMN is more effectively activated to a 
mutagen with preparations from the livers of ethanol pretreated 
rats than from controls (Garro, 1981; Smith, 1984). The 
alpha-carbon hydroxylation, which is mediated by cytochrome-P450 
mono-oxygenases is a crucial step in the bioactivation of 
N-nitrosamines to ultimate genotoxic species (Lai, 1980). 
Experiments with DMN have shown that the activity of the 
microsomal cytochrome-P450 dependent DMN-demethylase which 
catalyzes the initial alpha-hydroxylation of DMN is increased by 
ethanol pretreatment (Garro, 1981; Schnellmann, 1984; Schwartz, 
1980; Smith, 1984). Maling et al. (1975) reported an enhanced 
hepatotoxicity of DMN after pretreatment of rats with ethanol. 
Olson et al. (1984) found a potentiation of unscheduled DNA 
synthesis, following exposure to DMN, with isolated hepatocytes 
from ethanol pretreated rats compared with hepatocytes from 
controls. Our observation that the mutagenicity of DMN and DEN 
is higher with hepatocytes from ethanol pretreated rats than with 
hepatocytes from control rats (Figure lb), is compatible with 
these findings. However, Griciute et al. (1981) and Teschke et 
al. (1983) found that ethanol failed to change the total number 
of tumors significantly in C57BL mice and rats, respectively. 
The antitubercular drug INH is mainly acetylated to acetyl-INH 
which in turn forms acetylhydrazine upon metabolic hydrolysis. 
The liberated acetylhydrazine can be converted by cytochrome-P450 
dependent metabolism into potent acylating agents, capable of 
reacting with cellular macromolecules (Timbrell, 1980). The 
importance of the N-acetylation reaction in the bioactivation of 
INH was also underlined by other investigators (Gatehouse, 1984; 
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Mitchell, 1975). Mitchell et al. (1975) showed an increased 
incidence of INH-hepatitis on rapid acetylators. Gatehouse et 
al. (1984) reported that the primary step in the metabolic 
activation of INH to mutagens, in the fluctuation assay appeared 
to be mediated by an N-acetyltransferase. In a study on rats 
(Thomas, 1977), ethanol increased the excretion of N-acetyl-INH. 
We therefore suggest that the increase in N-acetylation and 
cytochrome-P450 content in the hepatocytes of the ethanol 
pretreated rats result in a more effective activation of INH by 
these cells, thereby explaining the observed increase in 
mutagenicity of INH after ethanol pretreatment (Figure le). 
Ethanol pretreatment resulted in an increase in the mutagenic 
activation of the cytostatic CP (Figure 1c). This may be due to 
the ethanol induced cytochrome-P450 dependent activation of CP. 
These results support the hypothesis that induction of the 
hepatic drug metabolizing system may be responsible for the 
ethanol induced increase in susceptibility to certain genotoxic 
agents. 
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SUMMARY 
The effect of alkylating agents on the content of free SH-groups 
in human, rat and rabbit hemoglobin was examined. Treatment of 
blood in vitro with iodoacetamide, styrene oxide and 
methylmethanesulfonate resulted in a dose-dependent decrease of 
free SH-groups in hemoglobin. The free SH-groups of rat 
hemoglobin were more susceptible to the alkylating agents tested 
than those of human and rabbit hemoglobin. The method is based 
on the isolation of hemoglobin and a subsequent measurement of 
the free SH-content of the hemoglobin by means of a 
spectrophotometric procedure. This procedure may be useful to 
examine differences in susceptibility of free SH-groups in 
hemoglobin, e.g. of different animal species, and on the other 
hand, to study the potencies of different electrophilic agents to 
alkylate these nucleophilic centers. 
INTRODUCTION 
Many compounds, including most chemical carcinogens, derive their 
injurious properties from their conversion into electrophilic 
metabolites, that can react with nucleophilic groups of cellular 
macromolecules. Other potential carcinogens are reactive 
electrophiles per se. These are alkylating, arylating or 
acylating agents, present in cigarette smoke, widely used as 
industrially significant reagents, but also as cytostatic drugs 
in chemotherapy of cancer. 
Ehrenberg and coworkers observed alkylated products of cysteine 
and histidine in hemoglobin after administration to mice of 
radiolabelled ethylene oxide (Ehrenberg, 1974), 
methylmethanesulfonate (Segerbäck, 1978), dimethylnitrosamine 
(Osterman-Golkar, 1976) , and vinyl chloride (Osterman-Golkar, 
1977). Furthermore, after administration to mice of 
radiolabelled methylmethanesulfonate, the amount of 
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S-methylcysteine and N-3-methylhistidine decreased linearly with 
time at the same rate as erythrocyte degradation (Segerbäck, 
1978). Pereira et al. (1981) also showed that a broad spectrum 
of chemical classes of carcinogens covalently bind to hemoglobin 
after administration of these compounds to rats. 
Between animal species great differences are known in the toxic 
effects of electrophilic agents. Interspecies differences may 
also be expected in the extent of the alkylation of nucleophilic 
groups, like free SH-groups in hemoglobin. 
In the present investigation we used a simple, non-selective 
method to examine the covalent binding of electrophiles to free 
SH-groups in hemoglobin of man, rat and rabbit. The method is 
based on the disappearance of free SH-groups in hemoglobin after 
treatment of blood with iodoacetamide, styrene oxide and 
methylmethanesulfonate. 
MATERIALS AND METHODS 
Chemicals 
Iodoacetamide and 4,4'-dithiopyridine were purchased from Janssen 
Chimica (Beerse, Belgium). Methylmethanesulfonate was obtained 
from Aldrich Chemical Co. Inc. (Milwaukee, USA). Styrene oxide 
was obtained from J.T. Baker Chemicals (Deventer, The 
Netherlands). All other chemicals used were of high purity. 
Blood samples 
Animal blood was collected under ether anesthesia by 
cardiopuncture with a heparinized syringe. Adult male Wistar 
rats and adult male New Zealand White rabbits were used. Samples 
of fresh heparinized blood of healthy male volunteers were 
obtained from a blood bank. 
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In vitro incubation of whole blood with alkylating agents 
In a shaking waterbath (210 rpm) closed sterile vials (i.d. 24 
mm, height 55 mm), each containing 3 ml of sterile heparinized 
blood and 100 ul of a sterile solution (in saline or DMSO) of the 
compound under test, were incubated at 37 oC for 5 h. 
Isolation and purification of human and rabbit hemoglobin 
After incubation, hemoglobin was isolated and purified as 
follows. The blood samples were suspended in 2 volumes of 
ice-cold PBS (phosphate-buffered saline (pH 8.0); lOmM 
Na-phosphate/150 mM NaCl) and centrifuged at 2300 xg at 4 oC for 
5 min. The supernatant and the buffy coat were removed by 
careful suction, and the erythrocytes were resuspended in 5 
volumes of ice-cold PBS. After mixing, the samples were 
centrifuged again at 2300 xg at 4 oC for 5 min. The supernatant 
was removed by careful suction, and a few erythrocytes were 
sacrificed to remove any remaining buffy layer. This washing 
procedure was repeated twice. The erythrocytes were then lysed 
carefully in 2 volumes of ice-cold distilled water on ice for 15 
min. Next, the ionic strength was brought to the original value 
by the addition of a 50 mM Na-phosphatebuffer (pH 8.0), 
containing 750 mM NaCl. The samples were then centrifuged at 
10000 xg at 4 oC for 20 min to remove cells and cellular debris. 
The supernatant was dialysed against PBS overnight (for 17 h; 
after 5 h the PBS was exchanged). 
Isolation and purification of rat hemoglobin 
The isolation and purification procedure was the same as for 
human and rabbit hemoglobin except for the use of PBS that was 
replaced by a 5 mM Tris-glycine-HCl buffer (pH 8.8), containing 
150 mM NaCl. The latter buffer was applied to prevent the 
crystallization of rat hemoglobin (Stein, 1971; Brunori, 1982; 
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Condò, 1981) 
Determination of hemoglobin content in the hemoglobin samples 
The hemoglobin assay is based on the hemiglobincyanide-procedure 
of van Kampen en Zijlstra (1961). Fifty microlitres of the 
hemoglobin sample was mixed with 2.5 ml of a buffer/reagent 
solution, made up of 1 mM KH2P04, 0.75 mM KCN and 0.6 mM 
K3Fe(CN)6, in brown-glass stoppered test tubes. The absorbance 
at 540 nm was read against water after 30 min of incubation in a 
waterbath at 25 oC. Longer delays did not affect the absorbance. 
Hemoglobin standards were used to estimate the molar extinction 
coefficient of the hemiglobincyanide formed, and showed to be 
10.5 χ IO3 M~1cm"1. 
Determination of sulfhydryl groups in hemoglobin 
Sulfhydryl groups were determined according to the procedure of 
Grassetti and Murray (1967), with slight modifications. The 
procedure is based on the reaction of 4,4'-dithiopyridine (4-PDS) 
with sulfhydryl groups, giving the corresponding 4-thiopyridone 
(4-TP). The ultraviolet absorption of the 4-TP formed, which is 
proportional to the sulfhydryl content of the sample, was 
measured at 324 nm. 
A stock solution of 1 mM 4-PDS was prepared by dissolving 
22 mg 4-PDS in 10 ml distilled water. Because of the relative 
insolubility of the uncharged 4-PDS in water, it was necessary to 
stir the solution at room temperature (protected from light) for 
approximately 2 h. The resulting solution proved to be stable 
for up to 2 months when stored at 4 oC. 
One hundred microlitres of each purified hemoglobin sample was 
diluted with 15 ml phosphate/EDTA-buffer (0.0282 M KH2P04/ 
0.0718M Na2HP04-buffer (pH 7.15), containing 1 mM EDTA). The 
diluted hemoglobin samples contained about 350 ug Hb/ml. 
Aliquots of 3 ml were mixed with 200 ul of a 1 mM 4-PDS solution 
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in brown-glass stoppered test tubes. The absorbance at 324 nm 
was read against water after 40 min of incubation in a waterbath 
at 25 oC. Longer delays did not affect the absorbance. An 
appropriate hemoglobin blank (made up of 3 ml of the hemoglobin 
solution and 200 ul aqua pure) and a 4-PDS blank (made up of 3 ml 
phosphate/EDTA-buffer and 200 ul of the 1 mM 4-PDS solution), 
were carried through incubation. All the incubations were done 
in duplicate. The sulfhydryl content of the hemoglobin samples 
was calculated from the corrected extinction value and the molar 
extinction coefficient of the 4-TP formed. Standard solutions of 
cysteine were used in the estimation of the molar extinction 
3 -1 -1 
coefficient of the 4-TP, and showed to be 20.5 χ 10 M cm 
Apparatus 
Spectra were taken on a Varían Cary 118 spectrophotometer. 
Absorption measurements were made on a Pye Unicam SP 1750 
spectrophotometer equipped with a flow-cell. 
RESULTS 
Calibration of the spectrophotometric Hb assay 
It was ascertained whether measurement of absorbance at 324 nm of 
Hb samples prepared from human, rat or rabbit blood can be used 
for the assay of Hb concentration in these samples. Therefore, 
samples with known Hb concentrations (accurately determined with 
the hemiglobincyanide-method as described in the "Materials and 
Methods" section) were diluted with phosphate/EDTA-buffer (pH 
7.15); subsequently the absorbance at 324 nm was measured against 
water. Figure 1 shows that the absorbance at 324 nm of human, 
rat and rabbit hemoglobin is a linear function of the Hb 
concentration. The absorption spectrum (250-650 nm) of the 
hemoglobin of man, rat and rabbit showed to be identical. 
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Fig. 1. Calibration of the absorbance at 324 nm of Hb samples prepared 
from human, rat and rabbit blood. Each point represents the average of 
three determinations (S.D. is less than O.S%). 
01 02 03 0.Í 
hemoglobin cone, (mg/ml) 
Fig. 2. Effect of the Hb concentration on the titration of SH-groups in 
hemoglobin of man, rat and rabbit, with 4-PDS. Each point represents the 
average of three determinations (S.D. is less than 0.5%). 
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Treatment of Hb with iodoacetamide, styrène oxide or 
methylmethanesulfonate did not alter these spectra. From the 
data of Figure 1 it can be calculated that 
Е
Н Ь
^ = 80 б χ 10 M cm This extinction coefficient was used 
M324 
in further experiments in the assay of the Hb concentration in 
the Hb samples. The advantage of this method is that the samples 
that serve as Hb blanks in the SH assay (see "Materials and 
Methods"), can be used for the determination of the Hb 
concentration at the same time. 
Free SH-groups in untreated hemoglobin of man, rat and rabbit 
The concentration of free SH-groups was derived from the 
concentration of 4-TP that is released during the reaction of 
4-PDS with the free SH-groups of hemoglobin. 4-TP concentrations 
were determined spectrophotometrically at 324 nm. The 
absorbances measured were corrected for the contribution of 4-PDS 
and Hb using a blank 4-PDS solution and the blank Hb samples 
(without 4-PDS). The absorbances at 324 nm due to the blank Hb 
samples were also used to calculate Hb concentrations as 
mentioned above. Figure 2 shows that the absorbance at 324 nm of 
the 4-TP, formed during the reaction of hemoglobin with 4-PDS, is 
proportional to the Hb concentration of the Hb samples tested. 
It can be calculated from these data that human as well as rabbit 
hemoglobin contain 2 free SH-groups and rat hamoglobin contains 5 
4-TP 3 -1 -1 
free SH-groups, by using a E M324
= 2 0
·
5 x 1 0 M c m
 · 
Disappearance of free SH-groups after alkylation 
The disappearance of free SH-groups in hemoglobin of man, rat and 
rabbit, after in vitro treatment of whole blood with 
iodoacetamide, styrene oxide and methylmethanesulfonate is 
illustrated in Figure 3. 
Figure 3a shows that the reaction of iodoacetamide with free 
150 
% reacted free SH-groups 
¿0 
!0 Human; Δ Rat; D Rabbit) 
С 
ι 
2 3 1 
concentration (mM) 
Fig. 3. Reaction of free SH-groups in hemoglobin of man,rat and r a b b i t a f t e r 
t reatment of whole blood i n - v i t r o with lodoacetamide (A), s tyrene oxide (B) 
and methylmethanesulfonate (C). Each point r e p r e s e n t s the average of two 
determinat ions (S.D. i s l e s s than 0.5%). 
SH-groups of human, r a t and r a b b i t hemoglobin i s 
c o n c e n t r a t i o n - d e p e n d e n t . R e l a t i v e l y high r e s p o n s e s were o b t a i n e d 
with the hemoglobin of a l l t h r e e s p e c i e s . 
S t y r e n e oxide r e a c t e d more e f f e c t i v e l y wi th t h e f ree SH-groups in 
r a t hemoglobin than human or r a b b i t hemoglobin. The r e s p o n s e of 
human and r a b b i t hemoglobin t o t h i s compound appeared t o be 
r e l a t i v e l y low. 
As p r e s e n t e d in F i g u r e 3c a s i m i l a r phenomenon was observed with 
m e t h y l m e t h a n e s u l f o n a t e which r e a c t e d with the f r e e SH-groups in 
hemoglobin of a l l t h r e e s p e c i e s . Rat hemoglobin, however, was 
most r e s p o n s i v e . 
I t was f u r t h e r s t u d i e d to a s c e r t a i n whether t h e low r e a c t i v i t y of 
t h e f r e e SH-groups in human hemoglobin t o m e t h y l m e t h a n e s u l f o n a t e 
might be due t o a f a i l u r e of t h i s compound t o p e n e t r a t e t h e 
e r y t h r o c y t e membrane or was t h e consequence of competing 
r e a c t i o n s with o t h e r n u c l e o p h i l i c groups in t h e b l o o d . 
T h e r e f o r e , m e t h y l m e t h a n e s u l f o n a t e was a l s o i n c u b a t e d wi th 
p u r i f i e d human hemoglobin i n s t e a d of whole b l o o d . After t h i s 
i n c u b a t i o n , however, subsequent a n a l y s i s aga in r e v e a l e d a very 
low r e s p o n s e , comparable t o t h a t o b t a i n e d with whole b l o o d . 
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DISCUSSION 
Human and rabbit blood each contain one major hemoglobin 
(Drysdale, 1971; Dayhoff, 1978) whereas rat blood has 4 major-
and 2 minor hemoglobins (Stein, 1971; Brunori, 1982; Dayhoff, 
1978). Friedman (1973)and Dayhoff (1978) reported 2 free 
SH-groups/hemoglobin tetramer in human and rabbit blood. Rat 
blood, however, contains six different hemoglobins, with 4,5 or 6 
free SH-groups (Condò, 1981). In human and rabbit hemoglobin 
only the cysteine, contains a reactive SH-group. In rat 
hemoglobin, besides the cysteine, also the cysteine 
contains a reactive SH-group (Condò, 1981); other cycteines may 
also be reactive. The cysteine in rat hemoglobin is located 
at the outside of the hemoglobin molecule and will therefore 
present a more prefered SH-group for alkylation than the 
cysteine, which is located inside the hemoglobin molecule. 
In accordance with this, the present results show 2 
SH-groups/human and per rabbit hemoglobin tetramer and 5 
SH-groups/rat hemoglobin tetramer reacting with 4-PDS (Figure 2). 
The results shown in Figure 3 demonstrate that exposure to 
increasing concentrations of the alkylating agents results in an 
increase in the percentage of free SH-groups that have reacted. 
The dose dependency of the response suggests that the loss of 
free SH-groups is the consequence of an interaction between these 
groups and the electrophi1ic agent. It is further illustrated in 
this figure that there are differences in the potency of 
electrophilic agents to react with free SH-groups in hemoglobin. 
Alkylation of free SH-groups in hemoglobin may depend on the 
concentration and reactivity of the electrophile and, in 
addition, on the presence, nucleophility and accessibility of the 
SH-groups. The latter is mainly determined by steric conditions. 
Variations in the number and position of the free SH-groups may 
be responsible for the observed differences in susceptibility to 
alkylation between rats on one hand, and humans and rabbits on 
the other (Figure 3). For methylmethanesulfonate, only minor 
alkylation of free SH-groups in human hemoglobin was found, both 
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after incubation with whole blood and with purified hemoglobin. 
So it seems unlikely that there is a penetration barrier for this 
alkylating agent. Possibly, the low reactivity of 
methylmethanesulfonate towards the free SH-groups is due to 
competing reactions with other amino acids in the hemoglobin, 
e.g. histidine. 
Detection of alkylated hemoglobin can be considered as an 
important tool in monitoring human exposure to electrophi1ic 
compounds. Therefore, several investigators have developed 
selective methods, like GC-MS analysis of modified amino acids of 
hemoglobin, which have proved to be very sensitive (Ehrenberg, 
1977; Calleman, 1978; Farmer, 1980 and 1982; Bailey, 1981). In 
this respect it remains doubtful whether the indirect assay of 
the alkylation of SH-groups, as described in this paper, because 
of its low sensitivity, is suitable for the detection of human 
exposures to low concentrations of electrophiles. Nevertheless, 
the simplicity of the procedure makes it suitable for routine 
uses, for instance to study the potency of various electrophilic 
chemicals to react with free SH-groups, and on the other hand, to 
examine strain- or species-dependent differences in 
susceptibility of hemoglobins to the action of alkylating agents. 
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GENERAL DISCUSSION AND CONCLUSIONS 
In-vitro/in-vivo differences 
It is questionable whether the metabolic activation of 
pregenotoxic chemicals by S9 fractions is representative for the 
biotransformation in-vivo. Several investigators have pointed 
out already that there are great differences in metabolite 
profiles, DNA-adduct profiles and mutagenicity responses, between 
in-vitro assays using metabolic activation with S9 preparations 
and those applying intact cells, showing that intact cells 
reflect the in-vivo situation more properly (Bartsch, 1983; Bos, 
1982; Bridges, 1980; Brouns, 1979; Gould, 1983; Selkirk, 1977). 
This consideration is affirmed by several results of the present 
thesis. In chapter III the mutagenicity of two structurally 
related carcinogenic arylamines, benzidine and 4-aminobiphenyl, 
after metabolic activation by S9 liver fractions or isolated 
intact hepatocytes, was investigated. It appeared that with 
intact hepatocytes the mutagenic responses more closely 
approximated those obtained with in-vivo bioactivation in 
animals. The different results between experiments with S9 and 
intact hepatocytes were found to be due to the lack of 
N-acetylating capacity of the S9. It appeared that no 
appropriate cofactor levels, i.e. acetyl-CoA were present in the 
subcellular S9 preparation of the liver. Consequently, 
activation reactions, e.g. N-acetylation in the case of 
benzidine, and deactivation reactions, e.g. N-acetylation in the 
case of 4-aminobiphenyl, are deficient in S9. This might result 
in unreliable predictions, in case the outcome of S9-dependent 
assays should be used in risk estimations. This phenomenon is 
again underlined by the results of studies on the mutagenicity of 
N-acetylbenzidine, N,N'-diacetylbenzidine and isoniazid (chapter 
IV and IX). Even for genotoxic compounds of other chemical 
classes it appeared that as well for rat as man the genotoxic 
activation by S9 greatly differed from that of the intact 
hepatocytes (chapter VII). 
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It is remarkable that, benzidine, dimethylnitrosamine, 
diethylnitrosamine and isoniazid were weakly- or non-mutagenic, 
when activated with rat or human liver S9, but highly mutagenic 
in the presence of intact hepatocytes (chapters III, VII, IX). 
The latter is well compatible with the high activity of these 
compounds in vivo. In contrast, B(a)P appeared highly mutagenic 
in the presence of rat liver S9, whereas with intact hepatocytes 
it was far less mutagenic. The latter is in accordance with the 
observation that the rat liver is not a target for the 
carcinogenic action of B(a)P in vivo. The relatively high 
activating potential of rat liver towards B(a)P, as can be 
concluded from the relatively high rate of metabolism of B(a)P 
(chapter VII, figure 2) will be present in S9 as well as in 
intact hepatocytes, however the known high activity of the liver 
glutathione conjugation reaction (deactivation) will only be 
present in intact hepatocytes (Brouns, 1979; Jernstörm, 1984). 
From the studies mentioned above it can be concluded that in 
in-vitro genotoxicity studies intact hepatocytes are a better 
model for the in-vivo bioactivation than the generally used S9 
liver fractions. Using subcellular preparations critical 
toxification as well as detoxification reactions may easily be 
overlooked. This explains, at least in part the many 
discrepancies between in-vivo and in-vitro (geno)toxicity data. 
The present results suggest that the use of isolated, intact 
cells can basically contribute to bridge the in-vitro/in-vivo 
gap. 
Interspecies differences 
Qualitative as well as quantitative differences in metabolism and 
susceptibility to genotoxic chemicals between species are well 
known (Clayson, 1983; Conney, 1974; ECETOC, 1982; Juchau, 1983; 
Kato, 1979; Motulsky, 1982; Streissinger, 1983). To have more 
insight in the underlying mechanisms of these variations several 
fundamental in-vitro studies were undertaken. 
In the chapters III-VI variations in genotoxicity of some 
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arylamines and arylamides were studied in relation to the 
particular potencies of bioactivation in isolated hepatocytes of 
several animal species and man. These studies revealed 
substantial quantitative as well as qualitative interspecies 
variations in the genotoxicity profiles. An obvious example was 
the relatively low activity of these compounds in the presence of 
hepatocytes from the guinea pig, a species reported to be 
resistant to the carcinogenic action of arylamines and 
arylamides, like 2-AF and 2-AAF. These studies showed that the 
balance between acetylation and deacetylation is one of the 
determinant factors in the ultimate genotoxicity of arylamines 
and arylamides in several species including man. On the other 
hand, interspecies differences in the N-hydroxylation, probably 
due to interspecies differences in substrate specificity of the 
cytochrome-P450 system towards these compounds, which are mainly 
determined by interspecies differences in isoenzymes composition, 
also play a crucial role in the ultimate genotoxicity. 
In chapter VII a more extensive evaluation of differences in 
metabolic activation between rat- (probably the most frequently 
used animal species in genotoxicity studies) and human liver 
preparations was obtained by studying the mutagenicity of 
compounds from different chemical classes, known to be activated 
via different metabolic routes. A striking observation was the 
difference in mutagenicity of B(a)P in the standard Ames-assay. 
The mutagenicity of B(a)P was high, when activated by rat liver 
S9 and low in the presence of human liver S9. This difference 
could be attributed to differences in B(a)P metabolism, namely to 
a far smaller capacity of the activating pathways in the human 
liver S9 compared with the rat liver S9 (chapter VII). 
Even with hepatocytes of a monkey (Macaca fascicular is) -a 
primate species evolutionary more closely related to man-, great 
qualitative and quantitative dissimilarities in genotoxic 
activation were seen when compared with human hepatocytes 
(chapter Vili). A striking difference was the high mutagenicity 
of В(a)Ρ in the presence of the monkey hepatocytes compared with 
the low activity in the presence of human hepatocytes. 
In chapter IX the genotoxicity was studied of the widely used 
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ant i tuberculous drug isoniazid. From clinical and animal 
research data it is known that this compound can produce, by 
electrophilic interactions, several types of liver injury (e.g. 
necrosis) in man. The rat liver, however, was resistant to it. 
Our results revealed that as far as the genotoxic activity of 
this drug is concerned, hepatocytes of certain human individuals 
are far more effective in bioactivating isoniazid to genotoxic 
products than rat hepatocytes. It was concluded that in studies 
of the genotoxic and/or hepatotoxic action of this drug the rat 
is not a proper model for man. 
Inter individual differences 
Even within one species, marked differences in the metabolic 
activation of chemicals to genotoxic products can be expected. 
This problem was approached by the studies described in chapter 
VII and IX. Isolated hepatocytes derived from different persons 
were examined for their ability to bioactivate several chemicals 
to mutagenic products. Considerable inter individual differences 
in activating potency were found, ranging to about 100-fold, 
depending on the chemical tested. Harris et al. (1984) reported 
that the quantity of carcinogen DNA-adducts formed in cultured 
human epithelial tissue expiants, after exposure to different 
chemical carcinogens, varied to 150-fold among cultured tissues 
from different people. These variations are not unexpected, if 
one takes into consideration the known great inter individual 
differences in the metabolism of xenobiotic chemicals (Dybing, 
1979; Harris, 1984; Moore, 1984; Motulsky, 1982; Nebert, 1983; 
Omenn, 1984) and the close relationship between metabolism and 
genotoxicity (e.g. chapter III-X). Most obvious were the great 
inter individual differences in metabolic activation of benzidine 
and isoniazid. It is noteworthy that the hepatocytes of 
individuals capable of more effectively activating benzidine were 
also more potent in activating isoniazid. These results 
correspond with earlier findings that liver N-acetylation of 
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isoniazid as well as benzidine are genetically controlled, 
dividing people in "slow and rapid acetylators". In chapter IX 
supporting evidence is presented for the hypothesis that rapid 
acetylator humans metabolize isoniazid more effectively to 
genotoxic products. To backbone this hypothesis and to find out 
whether this hypothesis also holds for benzidine, further 
investigations with human liver preparations have to be done. 
McQueen et al. (1983) have shown that benzidine was far more 
effectively activated to DNA-damaging products by hepatocytes of 
rapid acetylator rabbits than slow acetylator rabbits, thereby 
giving support to the above mentioned hypothesis. 
In addition to the genetic predisposition, the degree of exposure 
to environmental modifiers, in particular enzymes inducers, can 
also be held responsible for the inter individual variations in 
(geno)toxic activation. It was suggested, therefore, that the 
fact that the hepatocytes derived from a heavy drinker showed a 
relative high capacity to activate certain chemicals to mutagens, 
was due to ethanol induction (chapter V). 
In chapter X this effect of ethanol was studied in rats. 
Prolonged ethanol feeding to rats influenced the capacity of 
isolated hepatocytes to activate several chemicals to mutagenic 
products. This study revealed that ethanol pretreatment led to 
several changes in the metabolic fate of the chemicals tested. 
These changes were held responsible for the observed alterations 
in genotoxicity. 
Target susceptibility 
Due to the large amount of data about the biotransformation of 
pretoxic compounds, there may be the risk of underestimating the 
significance of non-metabolic factors, that determine the rate of 
electrophilic attack, e.g. the sensitivity of the target 
molecules. In the framework of the present thesis minor 
attention was given to this problem. 
Chapter XI was devoted to a study of the alkylation of free 
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SH-groups in hemoglobin of different species including man by 
direct alkylating agents. In other words, the interaction was 
measured of nucleophilic targets with agents that do not need 
metabolic activation. Significant interspecies differences were 
observed in the susceptibility of the free SH-groups towards 
alkylation. It was observed that free SH-groups in rat 
hemoglobin were far more sensitive than those of rabbit and man. 
This variation is probably due to the existence of "hot" free 
SH-groups in the rat hemoglobin. 
Several reports have also indicated the existence of so-called 
"hot-spots" in the DNA, showing these parts of the DNA to be far 
more susceptible to DNA-damage than other parts. It is likely to 
assume that these hot-spots are subject to species-, sex- or even 
inter individual differences resulting in variations in 
susceptibility to genotoxic compounds. 
Concluding remarks 
To ensure a safe utilization of man-made and other chemicals in 
our society a tremendous amount of compounds has to be tested for 
their potential (geno)toxicity. Until recently these studies 
were performed for the greater part with intact animals. 
Animal-bioassays, however, have evolved to be highly complex, 
extremely expensive and time consuming experiments, involving 
large numbers of animals. Therefore, the need has developed for 
more ethical and economical methodologies. This led to the 
development of a great diversity of short-term in-vitro screening 
assays. However, there is much concern about the predictive 
value of results obtained from in-vitro (geno)toxicity studies. 
Several reports, including the present thesis have demonstrated, 
however, that the gap between in-vitro and in-vivo studies might 
be bridged partly by the use of intact cell-systems, reflecting 
some typical features of total organisms. Thereby, reinforcing 
the value of in-vitro investigations for (geno)toxicity 
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evaluation. 
Extrapolations to humans from observed effects in animals in-vivo 
are seriously hampered by strain- and species differences in 
susceptibility among experimental animals. This is mostly caused 
by variations in biotransformation. The availability of human 
in-vivo genotoxicity data is limited (fortunately). Moreover, 
cause and effect relationships are difficult to establish in 
humans. There is no simple approach for this complicated 
problem. Appropriate in-vitro studies using human target tissue 
or cells may bring relief. As is demonstrated in the present 
thesis, isolated hepatocytes can be used for metabolic activation 
and/or as target cells. Extension of the use of such experiments 
to studies in which isolated human liver cells are co-incubated 
or co-cultivated with human cells of other organs or tissues 
(e.g. lung, kidney, skin) will even strengthen this approach. 
Recently, Strom et al. (1983) have used isolated human 
hepatocytes as metabolic entity together with human fibroblasts 
as target cells, to study the genotoxicity of several chemicals. 
In terms of risk identification, such findings are still very 
preliminary and many further studies are needed. However, in 
view of a serious attempt to replace in-vivo animal experiments 
by in-vitro research, it is a challenging question whether, by 
the use of human in-vitro cell-systems, the two-step 
extrapolation (from animal in-vitro to animal in-vivo and from 
animal in-vivo to man in-vivo) can be passed over (Figure 1: 
step 3, instead of step 1 + 2 ) or, on the other hand, whether 
human cell-systems are valuable but additional tools only. The 
results of the present thesis are promising in both aspects. 
EFFECTS IN ANIMAL 
TN VITRO SYSTEMS 
^EFFECTS IN HUMAN^ 
ÍIN VITRO SYSTEMS^ 
FFFECTS IN ANIMALS 
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^ EFFECTS IN MAN ^ 
Ж^^^^^^Е 
Fig. 1. Extrapolation of toxicoloqical data fron various experimental systems 
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SUMMARY 
Many body-foreign compounds are capable, mostly after metabolic 
activation, to evoke in the organism a diversity of genotoxic 
effects. Great inter- and intraspecies differences in 
susceptibility to potentially genotoxic chemicals are known. The 
underlying mechanisms of these variations are not fully 
understood. 
The present thesis was primarily directed to obtain more insight 
in these variations. Attention was mainly focussed on 
differences in metabolic activation as a cause of dissimilaries 
in effects. In-vitro studies were performed with some genotoxic 
model-compounds using isolated hepatocytes of different species, 
as metabolic entity and/or as the target cells. Apart from 
intact hepatocytes also a subcellular liver fraction, i.e. the 
9000 xg supernatant (S9), was used as a metabolic system. The 
species were rat, hamster, guinea pig, dog, monkey and man. 
Great discrepancies in metabolic activation of genotoxic 
chemicals between S9 liver fractions and intact hepatocytes were 
observed, showing that intact hepatocytes reflected more properly 
the bioactivation in-vivo. Benzidine and dimethylnitrosamine, 
for instance, were almost non-mutagenic when activated by rat and 
human S9 liver fractions, whereas in the presence of intact 
hepatocytes of either species high mutagenicity values were 
found. In addition, qualitative differences were observed. 
Benzidine was far more mutagenic than 4-aminobiphenyl when 
activated with intact rat hepatocytes, however in the presence of 
S9 liver fractions the reverse was found. 
The results obtained suggest that a great part of the existence 
of species-, strain-, sex- and other inter individual differences 
in susceptibility to genotoxic compounds may be attributed to 
differences in activation and deactivation processes that are 
influenced by genetic and/or environmental factors. 
Ethanol-feeding to rats, for instance, influenced the capacity of 
isolated hepatocytes to activate benzidine, dimethylnitrosamine, 
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cyclophosphamide and isoniazid, to mutagenic products by changing 
the metabolic fate of these compounds. Isoniazid, a widely used 
anti tuberculous drug, appeared to be non-genotoxic when activated 
by rat hepatocytes, however, in the presence of human hepatocytes 
of certain subjects it was found to be highly genotoxic. 
Indications were obtained that the latter phenomenon is 
associated with the genetic predisposition of the human subject 
for high or low capacity of hepatic N-acetylation. 
Furthermore, interspecies differences were found in the 
susceptibility of target centers in certain macromolecules, i.e. 
the free SH-groups in hemoglobin, towards electrophilic attack. 
In defining factors underlying inter- and intraspecies 
specificity of potentially genotoxic chemicals, in-vitro systems 
of intact cells have been shown a valuable tool. The use of 
human (liver)cells in in-vitro studies offers the oppertunity to 
obtain by experiments genotoxicity data concerning man, the 
species of primary interest. 
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SAMENVATTING 
Veel lichaamsvreemde stoffen zijn in staat om in het organisme, 
meestal na metabole activering, meerdere genotoxische effecten te 
bewerkstelligen. Aanzienlijke inter- en intraspecies verschillen 
in de gevoeligheid voor potentieel genotoxische chemicaliën zijn 
bekend. De mechanismen die hieraan ten grondslag liggen zijn 
veelal nog onduidelijk. 
Dit proefschrift is er primair op gericht om meer inzicht te 
verkrijgen in deze verschillen, met de nadruk op de metabole 
activering als mogelijke oorzaak. Bij in-vitro studies, 
uitgevoerd met enkele genotoxische modelstoffen, werd gebruik 
gemaakt van geïsoleerde hepatocyten van verschillende species. 
De hepatocyten fungeerden als metabool activerend systeem en/of 
als de "target" cellen. Daarnaast werd ook een subcellulaire 
leverfractie, namelijk 9000 xg supernatant (S9), gebruikt als 
metaboliserend systeem. De volgende species werden gebruikt, 
rat, cavia, hamster, hond, aap en de mens. 
Grote discrepanties werden gevonden in metabole activering van 
genotoxische stoffen tussen S9 lever fracties enerzijds en intacte 
hepatocyten anderzijds. Hieruit bleek dat de intacte hepatocyten 
op een meer betrouwbare wijze de in-vivo bioactiver ing weergeven. 
Bijvoorbeeld, benzidine en dimethylnitrosamine bijvoorbeeld, 
waren nagenoeg niet-mutageen na activering met ratte- en humane 
S9 leverfracties, terwijl in aanwezigheid van intacte hepatocyten 
van elk van beider species een hoge mutageniteit werd gevonden. 
Tevens werden kwalitatieve verschillen gevonden. Benzidine bleek 
veel mutagener dan 4-aminobiphenyl na metabole activering met 
intacte rattehepatocyten, terwijl in aanwezigheid van S9 
leverfracties het omgekeerde werd gevonden. 
De verkregen resultaten wijzen erop dat een groot deel van de 
species-, stam-, geslachts- en overige inter individuele 
verschillen in gevoeligheid voor genotoxische stoffen kunnen 
worden toegeschreven aan verschillen in activerings- en 
deactiverings processen. Deze processen worden beïnvloed door 
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genetische en/of omgevingsfactoren. Enkele voorbeelden mogen dit 
verduidelijken. Toediening van ethanol aan ratten via het 
drinkwater had grote invloed op de capaciteit van de geïsoleerde 
hepatocyten om benzidine, dimethylnitrosamine, cyclofosfamide en 
isoniazide, om te zetten in mutagene producten. Dit effect was 
het gevolg van een verandering van het metabolisme van deze 
stoffen. Isoniazide, een veel gebruikt geneesmiddel tegen 
tuberculose, bleek niet genotoxisch te zijn na activering met 
rattehepatocyten, terwijl het na metabole activering met humane 
hepatocyten afkomstig van sommige personen, sterk genotoxisch 
bleek te zijn. Er werden aanwijzingen gevonden dat dit laatst 
genoemde fenomeen verband houdt met een genetische predispositie 
voor een hoge of lage N-acetyleringscapaciteit van de lever 
("snelle en langzame acetyleerders"). 
Op het gebied van de gevoeligheid van bepaalde "target-centra" 
van macromoleculen voor electrofiele agentia werden eveneens 
interspecies verschillen gevonden. Dit betreft met name de 
alkyleerbaarheid van vrije SH-groepen in hemoglobine. 
Uit de resultaten van dit proefschrift blijkt, dat in-vitro 
systemen waarin intacte cellen worden gebruikt een waardevol 
hulpmiddel zijn bij het bestuderen van factoren die ten grondslag 
liggen aan inter- en intraspecies specificiteit van potentieel 
genotoxische chemicaliën. Het gebruik van humane (lever)cellen 
bij in-vitro studies biedt de mogelijkheid om via experimenten 
genotoxische gegevens te verkrijgen die betrekking hebben op de 
mens, de species waarin we primair geïnteresseerd zijn. 
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behorende bij het proefschrift 
VARIATION IN GENOTOXICITY 
DUE TO DIFFERENCES IN METABOLIC ACTIVATION 
Studies with isolated hepatocytes of 
different species, including man 
Nijmegen, 17 januari 1986. J.M. Neis. 
I 
Віэ de ontwikkeling van methoden voor biologische-monitoring 
m.b.v. proefdieren moet men zich ervan bewust zi]n dat de toe­
pasbaarheid van de ontwikkelde technieken onderhevig is aan 
interspecies verschillen. 
Npib, J.M. et al. (1984) Toxioology, 31, 319-3??. 
Dzt Proefschrift. 
II 
Voor bestudering van de activering van genotoxische stoffen is 
toepassing van geïsoleerde hepatocyten te verkiezen boven het 
gebruik van subcellulaire fracties van de lever, zoals het veel 
gebruikte 9000 xg supernatans (S9-fractie). 
Dit Proefschrift. 
III 
Gezien de sterk remmende werking van dimethylsulfoxide (DMSO) op 
de mutageniteit van o.a. N-nitrosodialkylamines, dient het ge-
bruik van dit oplosmiddel in mutageniteitstesten zoveel mogelijk 
te worden vermeden. 
Mon, ï. et al. (198SJ Mutation Research, 142, 163-158. 
Dit Proefschrift. 
IV 
Kankerverwekkende "peroxisome proliferators", waaronder meerdere 
serumlipidenverlagende stoffen, moeten op grond van het voorge-
stelde werkingsmechanisme gezien worden als een aparte klasse 
van chemische carcinogenen. 
Heddy, J.K. and D.L. Azarnoff (1980) Nature, 283, 397-398. 
V 
Bi] de teratogemteitsproblematiek wordt in verhouding te weinig 
aandacht geschonken aan schadeli]ke invloeden tijdens de precon-
ceptionele fase als oorzaak voor teratogene effecten. 
VI 
Het steeds verder verhogen van de gevoeligheid van geavanceerde 
analytische technieken om exposities aan toxische verbindingen 
te detecteren getuigt niet altijd van realiteitszin. 
VII 
De hardnekkigheid waarmee de D-glucaarzuurbepaling in urine 
telkens weer wordt aangeprezen als lever-enzyminductietest is 
onverklaarbaar en mist iedere wetenschappelijke onderbouwing. 
Brouwer, E. (1985) LAB/ABC, 11, 28-32. 
Notten, W.R.F. (1975! Alteration in the D-gluauronia aaid pathway 
and drug metabolism by exogenous compounds. Proefschrift, K.U. 
Nijmegen. 
Vili 
De toenemende vraag naar niet-rokers in contactadvertenties kan 
gezien worden als een eigentijdsverschijnsel waardoor de bewust-
wording van de gezondheidsrisico's van het passie f-roken wordt 
onderstreept. 
De Volkskrant, 19 november 1985, Rubriek: Dag In. 
Bos, R.P. and P.Th. Henderson (1984) Reviews on Environmental 
Health, 4, 161-178. 
IX 
De mogelijke aanwezigheid van verontreinigingen van prokaryo-
tische afkomst in Produkten vervaardigd via de biotechnologie 
vraagt grondig toxicologisch onderzoek. 
X 
De paleolitische voeding zou een voorbeeld functie moeten ver-
vullen binnen de moderne voedingsleer. 
Eaton, S.B. and M. Konner (1985) The New England Journal of 
Medicine, 312, 283-289. 
XI 
De eerste bacteriën (met een flagella in de vorm van een rechts-
gedraaide helix) waarvan werd ontdekt dat ze zowel voorwaarts als 
achterwaarts kunnen bewegen door de draairichting van de flagella 
te veranderen, zijn niet de door Spencer et al. (1985) als zoda-
nig genoemde Halobactenum species, maar Claustobacter crecentus. 
Spencer, M. (1985) Nature, 313, 183-185. 
Koyasu, S. et al. (1985) Nature, 314, 20. 
XII 
9-Anthryldiazomethaan blijkt een zeer bruikbaar reagens voor de 
"fluorescent labeling" van carboxylgroepen in aminozuren. 
Tsuguchika, Y. et al. (1985) Journal of Chromatography, 348, 
425-429. 



